<SEC-DOCUMENT>0001140361-22-045890.txt : 20221216
<SEC-HEADER>0001140361-22-045890.hdr.sgml : 20221216
<ACCEPTANCE-DATETIME>20221216164730
ACCESSION NUMBER:		0001140361-22-045890
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221216
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221216
DATE AS OF CHANGE:		20221216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EASTGROUP PROPERTIES INC
		CENTRAL INDEX KEY:			0000049600
		STANDARD INDUSTRIAL CLASSIFICATION:	REAL ESTATE INVESTMENT TRUSTS [6798]
		IRS NUMBER:				132711135
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07094
		FILM NUMBER:		221468551

	BUSINESS ADDRESS:	
		STREET 1:		400 W. PARKWAY PLACE
		STREET 2:		SUITE 100
		CITY:			RIDGELAND
		STATE:			MS
		ZIP:			39157
		BUSINESS PHONE:		6013543555

	MAIL ADDRESS:	
		STREET 1:		400 W. PARKWAY PLACE
		STREET 2:		SUITE 100
		CITY:			RIDGELAND
		STATE:			MS
		ZIP:			39157

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EASTGROUP PROPERTIES II INC
		DATE OF NAME CHANGE:	19970529

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICM REALTY
		DATE OF NAME CHANGE:	19830719
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ny20006293x2_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:egp="http://eastgroup.net/20221216" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_0cc1d4f2056c4beda6a56cfbcfb41bb2" contextRef="c20221216to20221216" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_b9cae21ff0ec47849ddf1bd1152b823a" contextRef="c20221216to20221216">0000049600</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="egp-20221216.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20221216to20221216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049600</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-16</xbrli:startDate><xbrli:endDate>2022-12-16</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

  <div style="text-align: center; font-size: 18pt; font-weight: bold;">UNITED STATES</div>

  <div style="text-align: center; font-size: 18pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

  <div style="text-align: center; font-weight: bold;">Washington, D.C. 20549</div>

  <div style="text-align: center; font-weight: bold;"><span style="text-decoration: underline;">__________________________</span></div>

  <div><br />
  </div>

  <div style="text-align: center; font-size: 12pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_fbfc371cef814cf78299ddec017ffde9" contextRef="c20221216to20221216">8-K</ix:nonNumeric></div>

  <div><br />
  </div>

  <div style="text-align: center; font-weight: bold;">CURRENT REPORT</div>

  <div style="text-align: center; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

  <div><br />
  </div>

  <div style="text-align: center;">Date of Report (date of earliest event reported):&#160; <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_cfd2bb6e082141788b95e6905a87f9fa" contextRef="c20221216to20221216" format="ixt:date-monthname-day-year-en">December 16, 2022</ix:nonNumeric></div>

  <div><br />
  </div>

  <div style="text-align: center; font-size: 12pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_1f9d7d7f39f14d12bf0a86b56a1d4400" contextRef="c20221216to20221216">EASTGROUP PROPERTIES, INC.</ix:nonNumeric><br />
  </div>

  <div style="text-align: center;">(Exact Name of Registrant as Specified in its Charter)</div>

  <div style="text-align: center;"> <br />
  </div>

  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top;">
          <div style="text-align: center; color: #000000;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_13f62b4dcb3d4f73969514baf712ee41" contextRef="c20221216to20221216" format="ixt-sec:stateprovnameen">Maryland</ix:nonNumeric><br />
          </div>
        </td>

    <td style="width: 33.88%; vertical-align: top;">
          <div style="text-align: center; color: #000000;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_c2d23bb3f46149749a2ce9f2e48ff05c" contextRef="c20221216to20221216">1-07094</ix:nonNumeric><br />
          </div>
        </td>

    <td colspan="2" style="vertical-align: top;">
          <div style="text-align: center; color: #000000;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_3d0069952e1e49a7b18c48f9f53f6c97" contextRef="c20221216to20221216">13-2711135</ix:nonNumeric><br />
          </div>
        </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: bottom;">
          <div style="text-align: center; color: #000000;">(State or Other Jurisdiction</div>
          <div style="text-align: center; color: #000000;">of Incorporation)</div>
        </td>

    <td style="width: 33.88%; vertical-align: top;">
          <div style="text-align: center; color: #000000;">(Commission File Number)</div>
        </td>

    <td colspan="2" style="vertical-align: bottom;">
          <div style="text-align: center; color: #000000;">(IRS Employer</div>
          <div style="text-align: center; color: #000000;">Identification No.)</div>
        </td>

  </tr>


</table>
  <div><br />
  </div>

  <div><br />
  </div>

  <div style="text-align: center; margin-left: 4.5pt;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_e10f3f5e48c0454fba15dfd44ed54a1a" contextRef="c20221216to20221216">400 W. Parkway Place</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_f5b0d41141f241d7b03a686d32f0dae1" contextRef="c20221216to20221216">Suite 100</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_1339b8a60e314a9aa92836ce2d6ec046" contextRef="c20221216to20221216">Ridgeland</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_19961e96bd6343868853d2a4b624c1ec" contextRef="c20221216to20221216">MS</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_661592a807e84ce99b1f7a09b07d488c" contextRef="c20221216to20221216">39157</ix:nonNumeric></div>

  <div style="text-align: center; margin-left: 4.5pt;">(Address of Principal Executive Offices, including zip code)</div>

  <div><br />
  </div>

  <div style="text-align: center;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_9455b81cd97648da936a385c4843641c" contextRef="c20221216to20221216">601</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_d3557124fd34412bb44e3e1744b65417" contextRef="c20221216to20221216">354-3555</ix:nonNumeric></div>

  <div style="text-align: center;">(Registrant&#8217;s telephone number, including area code)</div>

  <div><br />
  </div>

  <div style="text-align: justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</div>

  <div>&#160;</div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3.47%; vertical-align: top;">
          <div style="text-align: center; color: #000000; font-family: 'Segoe UI Symbol';"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_1f3a4beaf97543a0a960838b60e1f6c1" contextRef="c20221216to20221216" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </div>
        </td>

    <td style="width: 96.53%; vertical-align: top;">
          <div style="color: #000000;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
        </td>

  </tr>

  <tr>

    <td style="width: 3.47%; vertical-align: top;">
          <div style="text-align: center; color: #000000; font-family: 'Segoe UI Symbol';"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_076d3ab4c7c94cf289d2c1d319c41063" contextRef="c20221216to20221216" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </div>
        </td>

    <td style="width: 96.53%; vertical-align: top;">
          <div style="color: #000000;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
        </td>

  </tr>

  <tr>

    <td style="width: 3.47%; vertical-align: top;">
          <div style="text-align: center; color: #000000; font-family: 'Segoe UI Symbol';"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_9ac2b1d6204f46f2829217a5335e57da" contextRef="c20221216to20221216" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </div>
        </td>

    <td style="width: 96.53%; vertical-align: top;">
          <div style="color: #000000;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
        </td>

  </tr>

  <tr>

    <td style="width: 3.47%; vertical-align: top;">
          <div style="text-align: center; color: #000000; font-family: 'Segoe UI Symbol';"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_0c3904ad4b69450ebf2f13d659c12a32" contextRef="c20221216to20221216" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </div>
        </td>

    <td style="width: 96.53%; vertical-align: top;">
          <div style="color: #000000;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
        </td>

  </tr>


</table>
  <div><br />
  </div>

  <div>Securities registered pursuant to Section 12(b) of the Act:</div>

  <div><br />
  </div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 40.51%; vertical-align: middle; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
          <div style="text-align: center; color: #000000; font-weight: bold;">Title of each class</div>
        </td>

    <td style="width: 12.59%; vertical-align: middle; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
          <div style="text-align: center; color: #000000; font-weight: bold;">Trading symbol(s)</div>
        </td>

    <td style="width: 46.9%; vertical-align: middle; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
          <div style="text-align: center; color: #000000; font-weight: bold;">Name of each exchange on which registered</div>
        </td>

  </tr>

  <tr>

    <td style="width: 40.51%; vertical-align: middle; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
          <div style="text-align: center; color: #000000;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_12ec10cd27b149039eb5104a1d747a33" contextRef="c20221216to20221216">Common stock, $0.0001 par value per share</ix:nonNumeric><br />
          </div>
        </td>

    <td style="width: 12.59%; vertical-align: middle; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
          <div style="text-align: center; color: #000000;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_e1dc135bfe6945acbbbdbbc9439957e3" contextRef="c20221216to20221216">EGP</ix:nonNumeric><br />
          </div>
        </td>

    <td style="width: 46.9%; vertical-align: middle; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
          <div style="text-align: center; color: #000000;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_7a16d78b2a374550861cfbe557abaa55" contextRef="c20221216to20221216" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric><br />
          </div>
        </td>

  </tr>


</table>
  <div>&#160;</div>

  <div>&#160;</div>

  <div style="text-align: justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2
    of this chapter).</div>

  <div>&#160;</div>

  <div style="text-align: justify;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_b846ca6e0dfa44dc91a1c1ac544a328a" contextRef="c20221216to20221216" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

  <div>&#160;</div>

  <div style="text-align: justify; font-size: 12pt;"><span style="font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size: 10pt; font-family: 'Segoe UI Symbol';">&#9744;</span></div>

  <div style="text-align: justify; font-size: 12pt;"><span style="font-size: 10pt; font-family: 'Segoe UI Symbol';"> <br />
    </span></div>

  <div style="text-align: justify; font-size: 12pt;">
    <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
<div><span style="font-size: 10pt; font-family: 'Segoe UI Symbol';"> </span></div>
</div>

  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

  </div>

  <div><span style="font-weight: bold;">Item 8.01</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold; color: #000000;">Other Events.</span></div>

  <div><br />
  </div>

  <div style="text-align: justify;">On December 16, 2022, EastGroup Properties, Inc. (the &#8220;<span style="text-decoration: underline;">Company</span>&#8221;) entered into a sales agency financing agreement (the &#8220;<span style="text-decoration: underline;">Sales Agreement</span>&#8221;) with Robert W. Baird &amp; Co. Incorporated, BNY Mellon Capital
    Markets, LLC, BofA Securities, Inc., BTIG, LLC, Jefferies LLC, Raymond James &amp; Associates, Inc., Regions Securities LLC, Samuel A. Ramirez &amp; Company, Inc., TD Securities (USA) LLC and Wells Fargo Securities, LLC (collectively, the &#8220;<span style="text-decoration: underline;">Agents</span>&#8221;),<span style="font-size: 12pt;">&#160;</span>pursuant to which the Company may offer and sell shares of its common stock having an aggregate offering price of up to $750,000,000 (the &#8220;<span style="text-decoration: underline;">Shares</span>&#8221;) from time to time in &#8220;at-the-market&#8221; offerings or certain
    other transactions through, at the Company&#8217;s discretion, any of the Agents as its sales agents or acting as principals (collectively, the &#8220;<span style="text-decoration: underline;">Offering</span>&#8221;).<span style="font-size: 12pt;">&#160;</span>The Sales Agreement has a term expiring upon the sale of
    all the Shares (unless it is terminated earlier by the parties) and provides that the Company will pay each of the Agents a commission which in each case shall not exceed 2.0% of the gross sales price of all Shares sold through it as the agent under
    the Sales Agreement.&#160; Upon entry into the Sales Agreement, the Company terminated the Company&#8217;s previous at-the-market program pursuant to those certain sales agency financing agreements, dated December 20, 2019 and July 28, 2021, respectively, as
    amended. At the time of such termination, shares of the Company&#8217;s common stock having an aggregate gross sales price of $305,468,446.59 remained unsold under such prior program.</div>

  <div><br />
  </div>

  <div style="text-align: justify;">Sales of the Shares, if any, may be made by means of ordinary brokers&#8217; transactions on the New York Stock Exchange at market prices, in negotiated transactions or by any other method permitted by law deemed to be an
    &#8220;at-the-market&#8221; offering as defined in Rule 415 under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline;">Act</span>&#8221;), including block transactions or sales made to or through a market maker other than on an exchange, at prices related to
    prevailing market prices or at negotiated prices. The Company may sell the Shares in amounts and at times to be determined by the Company from time to time, but has no obligation to sell any of the Shares in the Offering, and may at any time suspend
    solicitation and offers under the Sales Agreements. Actual sales will depend on a variety of factors to be determined by the Company from time to time, including (among others) market conditions, the trading price of the Company&#8217;s common stock,
    determinations by the Company of the optimal source of funding for the Company and potential uses of the funding available to the Company. The Company intends to use the net proceeds of the Offering for general corporate purposes, which may include
    working capital, the repayment of amounts outstanding from time to time under the Company&#8217;s unsecured revolving credit facilities or other indebtedness and the payment of costs of acquisition or development of industrial properties, or a combination
    thereof.</div>

  <div><br />
  </div>

  <div style="text-align: justify;">The above summary is qualified in its entirety by reference to the Sales Agreement attached as Exhibit 1.1 to this Current Report on Form 8-K, which is incorporated herein by reference.</div>

  <div><br />
  </div>

  <div style="text-align: justify;">The Shares will be issued pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission on December 16, 2022 (File No. 333-268821), and a prospectus supplement, dated December
    16, 2022, filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Act.</div>

  <div><br />
  </div>

  <div style="text-align: justify;">In connection with the filing of the prospectus supplement, the Company is filing as Exhibit 5.1 to this Current Report on Form 8-K an opinion of its counsel, Goodwin Procter LLP.</div>

  <div><br />
  </div>

  <div style="text-align: justify;">This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company, nor shall there be any sale of such securities in any jurisdiction in which such
    offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.</div>

  <div><br />
  </div>

  <div><span style="font-weight: bold; color: #000000;">Item 9.01</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold; color: #000000;">Financial Statements and Exhibits.</span></div>

  <div><br />
  </div>

  <div>(d) Exhibits.</div>

  <div><br />
  </div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 12.31%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div>Exhibit No.</div>
        </td>

    <td style="width: 2.87%; vertical-align: top;">&#160;</td>

    <td style="width: 84.82%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div>Description</div>
        </td>

  </tr>

  <tr>

    <td style="width: 12.31%; vertical-align: top;">
          <div><a href="ny20006293x2_ex1-1.htm">1.1</a></div>
        </td>

    <td style="width: 2.87%; vertical-align: top;">&#160;</td>

    <td style="width: 84.82%; vertical-align: top;">
          <div style="text-align: justify;">Sales Agency Financing Agreement, dated December 16, 2022, by and among the Company, Robert W. Baird &amp; Co. Incorporated, BNY Mellon Capital Markets, LLC, BofA Securities, Inc., BTIG, LLC, Jefferies LLC,
            Raymond James &amp; Associates, Inc., Regions Securities LLC, Samuel A. Ramirez &amp; Company, Inc., TD Securities (USA) LLC and Wells Fargo Securities, LLC</div>
        </td>

  </tr>

  <tr>

    <td style="width: 12.31%; vertical-align: top;">
          <div><a href="ny20006293x2_ex5-1.htm">5.1</a></div>
        </td>

    <td style="width: 2.87%; vertical-align: top;">&#160;</td>

    <td style="width: 84.82%; vertical-align: top;">
          <div style="text-align: justify;">Opinion of Goodwin Procter LLP as to the legality of the securities being registered</div>
        </td>

  </tr>

  <tr>

    <td style="width: 12.31%; vertical-align: top;">
          <div><a href="ny20006293x2_ex5-1.htm">23.1</a></div>
        </td>

    <td style="width: 2.87%; vertical-align: top;">&#160;</td>

    <td style="width: 84.82%; vertical-align: top;">
          <div style="text-align: justify;">Consent of Goodwin Procter LLP (included in Exhibit 5.1)</div>
        </td>

  </tr>

  <tr>

    <td style="width: 12.31%; vertical-align: top;">
          <div>104</div>
        </td>

    <td style="width: 2.87%; vertical-align: top;">&#160;</td>

    <td style="width: 84.82%; vertical-align: top;">
          <div style="text-align: justify;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
        </td>

  </tr>


</table>
  <div><br />
  </div>

  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

  </div>

  <div><br />
  </div>

  <div style="text-align: center; font-weight: bold;">SIGNATURES</div>

  <div><br />
  </div>

  <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

  <div><br />
  </div>

  <div>Date:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;December 16, 2022</div>

  <div><br />
  </div>

  <div>&#160;</div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 60.57%; vertical-align: top;">
          <div style="color: #000000;">&#160;</div>
        </td>

    <td style="width: 39.43%; vertical-align: top;">
          <div style="color: #000000;">EASTGROUP PROPERTIES, INC.</div>
        </td>

  </tr>

  <tr>

    <td style="width: 60.57%; vertical-align: top;">
          <div style="color: #000000;">&#160;</div>
        </td>

    <td style="width: 39.43%; vertical-align: top;">
          <div style="color: #000000;">&#160;</div>
        </td>

  </tr>

  <tr>

    <td style="width: 60.57%; vertical-align: top;">
          <div style="color: #000000;">&#160;</div>
        </td>

    <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 39.43%;">
          <div style="color: #000000;">By: /s/ Brent W. Wood</div>
        </td>

  </tr>

  <tr>

    <td style="width: 60.57%; vertical-align: top;">
          <div style="color: #000000;">&#160;</div>
        </td>

    <td style="border-top: 0px none #000000; vertical-align: bottom; width: 39.43%;">
          <div style="color: #000000;">Brent W. Wood</div>
          <div style="color: #000000;">Executive Vice President, Chief Financial Officer and Treasurer</div>
        </td>

  </tr>


</table>
  <div><br />
  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ny20006293x2_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">
  <!-- Field: Rule-Page -->
  <!-- Field: /Rule-Page -->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <p style="margin: 0; text-align: right"><b>Exhibit 1.1</b></p>
  <p style="margin: 0">&#160;</p>
  <p style="margin: 0; text-align: right">EXECUTION VERSION</p>
  <p style="margin: 0; text-align: right">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of December 16, 2022</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <br>
  </p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EASTGROUP PROPERTIES, INC.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><font style="text-transform: none">and</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">ROBERT W. BAIRD &amp; CO. <font style="text-transform: none">INCORPORATED</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">BNY MELLON CAPITAL MARKETS, LLC</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">BOFA SECURITIES, INC.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">BTIG, LLC</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">JEFFERIES LLC</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">RAYMOND JAMES &amp; ASSOCIATES, INC.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">REGIONS SECURITIES LLC</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">Samuel A. Ramirez &amp; Company, Inc.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">TD SECURITIES (USA) LLC</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">WELLS FARGO SECURITIES, LLC</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <!-- Field: Rule-Page -->
  <div align="CENTER" style="margin-top: 0pt; margin-bottom: 0pt">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 50%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><b> <br>
    </b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><b>SALES AGENCY FINANCING AGREEMENT</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><b> <br>
    </b></p>
  <p style="margin: 0">&#160;</p>
  <!-- Field: Rule-Page -->
  <div align="CENTER" style="margin-top: 0pt; margin-bottom: 0pt">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 50%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Page</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="width: 100%">

      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td colspan="3">ARTICLE I DEFINITIONS</td>
        <td style="text-align: right">1</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 5%; padding-top: 6pt">&#160;</td>
        <td style="width: 12%; padding-top: 6pt;">Section 1.01</td>
        <td style="width: 78%; padding-top: 6pt;">Certain Definitions</td>
        <td style="text-align: right; width: 5%; padding-top: 6pt">1</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td colspan="3" style="padding-top: 6pt">ARTICLE II ISSUANCE AND SALE OF COMMON STOCK</td>
        <td style="text-align: right; padding-top: 6pt">5</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 2.01</td>
        <td style="padding-top: 6pt;">Issuance</td>
        <td style="text-align: right; padding-top: 6pt">5</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 2.02</td>
        <td style="padding-top: 6pt;">Effectiveness</td>
        <td style="text-align: right; padding-top: 6pt">6</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 2.03</td>
        <td style="padding-top: 6pt;">Mechanics of Issuances</td>
        <td style="text-align: right; padding-top: 6pt">7</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 2.04</td>
        <td style="padding-top: 6pt;">Settlements</td>
        <td style="text-align: right; padding-top: 6pt">8</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 2.05</td>
        <td style="padding-top: 6pt;">Use of Free Writing Prospectus</td>
        <td style="text-align: right; padding-top: 6pt">9</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 2.06</td>
        <td style="padding-top: 6pt;">Material Non-Public Information</td>
        <td style="text-align: right; padding-top: 6pt">9</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 2.07</td>
        <td style="padding-top: 6pt;">Exemption from Regulation&#160;M</td>
        <td style="text-align: right; padding-top: 6pt">9</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td colspan="3" style="padding-top: 6pt">ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY</td>
        <td style="text-align: right; padding-top: 6pt">9</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.01</td>
        <td style="padding-top: 6pt;">Registration</td>
        <td style="text-align: right; padding-top: 6pt">9</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.02</td>
        <td style="padding-top: 6pt;">Incorporated Documents</td>
        <td style="text-align: right; padding-top: 6pt">10</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.03</td>
        <td style="padding-top: 6pt;">Registration Statement; Prospectus and Disclosure Package</td>
        <td style="text-align: right; padding-top: 6pt">11</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.04</td>
        <td style="padding-top: 6pt;">Changes</td>
        <td style="text-align: right; padding-top: 6pt">11</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.05</td>
        <td style="padding-top: 6pt;">Organizational Matters</td>
        <td style="text-align: right; padding-top: 6pt">12</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.06</td>
        <td style="padding-top: 6pt;">Authorization; Enforceability</td>
        <td style="text-align: right; padding-top: 6pt">12</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.07</td>
        <td style="padding-top: 6pt;">Capitalization</td>
        <td style="text-align: right; padding-top: 6pt">12</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.08</td>
        <td style="padding-top: 6pt;">No Conflicts</td>
        <td style="text-align: right; padding-top: 6pt">13</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.09</td>
        <td style="padding-top: 6pt;">Legal Proceedings</td>
        <td style="text-align: right; padding-top: 6pt">14</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.10</td>
        <td style="padding-top: 6pt;">Sale of Common Shares</td>
        <td style="text-align: right; padding-top: 6pt">14</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.11</td>
        <td style="padding-top: 6pt;">Permits</td>
        <td style="text-align: right; padding-top: 6pt">14</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.12</td>
        <td style="padding-top: 6pt;">Investment Company</td>
        <td style="text-align: right; padding-top: 6pt">14</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.13</td>
        <td style="padding-top: 6pt;">Financial Condition; No Adverse Changes</td>
        <td style="text-align: right; padding-top: 6pt">14</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.14</td>
        <td style="padding-top: 6pt;">Use of Proceeds</td>
        <td style="text-align: right; padding-top: 6pt">16</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.15</td>
        <td style="padding-top: 6pt;">Environmental Matters</td>
        <td style="text-align: right; padding-top: 6pt">16</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.16</td>
        <td style="padding-top: 6pt;">Insurance</td>
        <td style="text-align: right; padding-top: 6pt">16</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.17</td>
        <td style="padding-top: 6pt;">Officer&#8217;s Certificate</td>
        <td style="text-align: right; padding-top: 6pt">16</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.18</td>
        <td style="padding-top: 6pt;">Finder&#8217;s Fees</td>
        <td style="text-align: right; padding-top: 6pt">16</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.19</td>
        <td style="padding-top: 6pt;">Non-affiliated Market Capitalization</td>
        <td style="text-align: right; padding-top: 6pt">17</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt;">Section 3.20</td>
        <td style="padding-top: 6pt;">Taxes</td>
        <td style="text-align: right; padding-top: 6pt">17</td>
      </tr>

  </table>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- i -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <table cellspacing="0" cellpadding="0" style="width: 100%">

      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 5%">&#160;</td>
        <td style="width: 12%; vertical-align: top;">Section 3.21</td>
        <td style="width: 78%;">Partnership Status</td>
        <td style="text-align: right; width: 5%">17</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 3.22</td>
        <td style="padding-top: 6pt;">REIT Status</td>
        <td style="text-align: right; padding-top: 6pt">17</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 3.23</td>
        <td style="padding-top: 6pt;">REIT Compliance</td>
        <td style="text-align: right; padding-top: 6pt">17</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 3.24</td>
        <td style="padding-top: 6pt;">Tax Disclosure</td>
        <td style="text-align: right; padding-top: 6pt">17</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 3.25</td>
        <td style="padding-top: 6pt;">Actively-Traded Security</td>
        <td style="text-align: right; padding-top: 6pt">18</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 3.26</td>
        <td style="padding-top: 6pt;">Anti-Bribery; Anti-Corruption</td>
        <td style="text-align: right; padding-top: 6pt">18</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 3.27</td>
        <td style="padding-top: 6pt;">Money Laundering</td>
        <td style="text-align: right; padding-top: 6pt">18</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 3.28</td>
        <td style="padding-top: 6pt;">Sanctions</td>
        <td style="text-align: right; padding-top: 6pt">18</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 3.29</td>
        <td style="padding-top: 6pt;">Cybersecurity</td>
        <td style="text-align: right; padding-top: 6pt">19</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td colspan="3" style="padding-top: 6pt">ARTICLE IV COVENANTS</td>
        <td style="text-align: right; padding-top: 6pt">20</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.01</td>
        <td style="padding-top: 6pt;">Registration Statement and Prospectus</td>
        <td style="text-align: right; padding-top: 6pt">20</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.02</td>
        <td style="padding-top: 6pt;">Blue Sky</td>
        <td style="text-align: right; padding-top: 6pt">21</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.03</td>
        <td style="padding-top: 6pt;">Copies of the Registration Statement and Prospectus</td>
        <td style="text-align: right; padding-top: 6pt">21</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.04</td>
        <td style="padding-top: 6pt;">Rule&#160;158</td>
        <td style="text-align: right; padding-top: 6pt">22</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.05</td>
        <td style="padding-top: 6pt;">Information</td>
        <td style="text-align: right; padding-top: 6pt">22</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.06</td>
        <td style="padding-top: 6pt;">Representations and Warranties</td>
        <td style="text-align: right; padding-top: 6pt">22</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.07</td>
        <td style="padding-top: 6pt;">Counsel Letters</td>
        <td style="text-align: right; padding-top: 6pt">23</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.08</td>
        <td style="padding-top: 6pt;">Comfort Letters</td>
        <td style="text-align: right; padding-top: 6pt">23</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.09</td>
        <td style="padding-top: 6pt;">Officers&#8217; Certificate</td>
        <td style="text-align: right; padding-top: 6pt">24</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.10</td>
        <td style="padding-top: 6pt;">Stand Off Agreement</td>
        <td style="text-align: right; padding-top: 6pt">24</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.11</td>
        <td style="padding-top: 6pt;">Market Activities</td>
        <td style="text-align: right; padding-top: 6pt">25</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.12</td>
        <td style="padding-top: 6pt;">REIT Status</td>
        <td style="text-align: right; padding-top: 6pt">25</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.13</td>
        <td style="padding-top: 6pt;">Maximum Program Amount</td>
        <td style="text-align: right; padding-top: 6pt">25</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 4.14</td>
        <td style="padding-top: 6pt;">Due Diligence</td>
        <td style="text-align: right; padding-top: 6pt">25</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td colspan="3" style="padding-top: 6pt">ARTICLE V CONDITIONS TO DELIVERY OF ISSUANCE NOTICES AND TO SETTLEMENT</td>
        <td style="text-align: right; padding-top: 6pt">26</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 5.01</td>
        <td style="padding-top: 6pt;">Conditions Precedent to the Right of the Company to Deliver an Issuance Notice and the Obligation of the Agents to Sell Common Shares During the Selling Period(s)</td>
        <td style="text-align: right; padding-top: 6pt">26</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 5.02</td>
        <td style="padding-top: 6pt;">Suspension of Sales</td>
        <td style="text-align: right; padding-top: 6pt">28</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td colspan="3" style="padding-top: 6pt">ARTICLE VI INDEMNIFICATION AND CONTRIBUTION</td>
        <td style="text-align: right; padding-top: 6pt">29</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 6.01</td>
        <td style="padding-top: 6pt;">Indemnification by the Company</td>
        <td style="text-align: right; padding-top: 6pt">29</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 6.02</td>
        <td style="padding-top: 6pt;">Indemnification by the Agents</td>
        <td style="text-align: right; padding-top: 6pt">29</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 6.03</td>
        <td style="padding-top: 6pt;">Conduct of Indemnification Proceedings</td>
        <td style="text-align: right; padding-top: 6pt">30</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 6.04</td>
        <td style="padding-top: 6pt;">Contribution</td>
        <td style="text-align: right; padding-top: 6pt">31</td>
      </tr>

  </table>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- ii -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <table cellspacing="0" cellpadding="0" style="width: 100%">

      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td colspan="3">ARTICLE VII TERMINATION</td>
        <td style="text-align: right">32</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt; width: 5%">&#160;</td>
        <td style="padding-top: 6pt; width: 12%; vertical-align: top;">Section 7.01</td>
        <td style="padding-top: 6pt; width: 78%;">Term</td>
        <td style="text-align: right; padding-top: 6pt; width: 5%">32</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 7.02</td>
        <td style="padding-top: 6pt;">Termination by an Agent</td>
        <td style="text-align: right; padding-top: 6pt">32</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 7.03</td>
        <td style="padding-top: 6pt;">Termination by the Company</td>
        <td style="text-align: right; padding-top: 6pt">32</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 7.04</td>
        <td style="padding-top: 6pt;">Liability; Provisions that Survive Termination</td>
        <td style="text-align: right; padding-top: 6pt">32</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td colspan="3" style="padding-top: 6pt">ARTICLE VIII REPRESENTATIONS AND WARRANTIES TO SURVIVE DELIVERY</td>
        <td style="text-align: right; padding-top: 6pt">33</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td colspan="3" style="padding-top: 6pt">ARTICLE IX MISCELLANEOUS</td>
        <td style="text-align: right; padding-top: 6pt">33</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.01</td>
        <td style="padding-top: 6pt;">Press Releases and Disclosure</td>
        <td style="text-align: right; padding-top: 6pt">33</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.02</td>
        <td style="padding-top: 6pt;">Expenses</td>
        <td style="text-align: right; padding-top: 6pt">33</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.03</td>
        <td style="padding-top: 6pt;">Notices</td>
        <td style="text-align: right; padding-top: 6pt">34</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.04</td>
        <td style="padding-top: 6pt;">Entire Agreement</td>
        <td style="text-align: right; padding-top: 6pt">35</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.05</td>
        <td style="padding-top: 6pt;">Amendment and Waiver</td>
        <td style="text-align: right; padding-top: 6pt">35</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.06</td>
        <td style="padding-top: 6pt;">No Assignment; No Third Party Beneficiaries</td>
        <td style="text-align: right; padding-top: 6pt">35</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.07</td>
        <td style="padding-top: 6pt;">Severability</td>
        <td style="text-align: right; padding-top: 6pt">35</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.08</td>
        <td style="padding-top: 6pt;">Further Assurances</td>
        <td style="text-align: right; padding-top: 6pt">35</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.09</td>
        <td style="padding-top: 6pt;">Titles and Headings</td>
        <td style="text-align: right; padding-top: 6pt">36</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.10</td>
        <td style="padding-top: 6pt;">Governing Law; Jurisdiction</td>
        <td style="text-align: right; padding-top: 6pt">36</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.11</td>
        <td style="padding-top: 6pt;">Waiver of Jury Trial</td>
        <td style="text-align: right; padding-top: 6pt">36</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.12</td>
        <td style="padding-top: 6pt;">Counterparts</td>
        <td style="text-align: right; padding-top: 6pt">36</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.13</td>
        <td style="padding-top: 6pt;">Adjustments for Stock Splits, etc.</td>
        <td style="text-align: right; padding-top: 6pt">36</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.14</td>
        <td style="padding-top: 6pt;">No Fiduciary Duty</td>
        <td style="text-align: right; padding-top: 6pt">36</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 6pt">&#160;</td>
        <td style="padding-top: 6pt; vertical-align: top;">Section 9.15</td>
        <td style="padding-top: 6pt;">Recognition of the U.S. Special Resolution Regimes</td>
        <td style="text-align: right; padding-top: 6pt">37</td>
      </tr>

  </table>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- iii -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This SALES AGENCY FINANCING AGREEMENT (this &#8220;<b>Agreement</b>&#8221;), dated as of December 16, 2022, is made by and between EASTGROUP PROPERTIES, INC.,
    a Maryland corporation (the &#8220;<b>Company</b>&#8221;), and Robert W. Baird &amp; Co. Incorporated, BNY Mellon Capital Markets, LLC, BofA Securities, Inc., BTIG, LLC, Jefferies LLC, Raymond James &amp; Associates, Inc., Regions Securities LLC, Samuel A. Ramirez
    &amp; Company, Inc., TD Securities (USA) LLC, and Wells Fargo Securities, LLC as sales agents and/or principals (each, an &#8220;<b>Agent</b>&#8221; or collectively, the &#8220;<b>Agents</b>&#8221;).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">W I T N E S S E T H:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company has authorized and proposes to issue and sell in the manner contemplated by this Agreement shares of the Company&#8217;s common
    stock, $0.0001 par value per share (&#8220;<b>Common Stock</b>&#8221;), having an aggregate gross sales price of up to $750,000,000, upon the terms and subject to the conditions contained herein; and</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Agents have been appointed by the Company as its agents to sell the Common Shares (as defined below) and agree to use their
    commercially reasonable efforts to sell the Common Shares offered by the Company from time to time upon the terms and subject to the conditions contained herein.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE, in consideration of the premises, representations, warranties, covenants and agreements contained herein, and for other good and
    valuable consideration, the receipt and sufficiency of which are hereby acknowledged, intending to be legally bound hereby, the parties hereto agree as follows:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="text-transform: uppercase">Article I</font><br>
    <br>
    DEFINITIONS</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.01<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Certain Definitions</b></font>. For purposes of this Agreement, capitalized terms used herein and not otherwise defined shall have the following respective meanings:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>1940 Act</b>&#8221; has the meaning set forth in Section&#160;3.12.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Actual Sold Amount</b>&#8221; means the number of Issuance Shares that each Agent has sold during the Selling Period.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Affiliate</b>&#8221; of a Person means another Person that directly or indirectly, through one or more intermediaries, controls, is controlled by,
    or is under common control with, such first-mentioned Person. The term &#8220;control&#8221; (including the terms &#8220;controlling,&#8221; &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) means the possession, direct or indirect, of the power to direct or cause the
    direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Agency Settlement Date</b>&#8221; means, in connection with the offer and sale of Common Shares from the Company to an Agent in their capacity as
    agents and not as principals, unless the Company and the applicable Agent shall otherwise agree, the second business day (or such earlier day as is industry practice for regular-way trading) following each Trading Day during the applicable Selling
    Period, when the Company shall deliver to such Agent the amount of Common Shares sold on such Trading Day and such Agent shall deliver to the Company the Issuance Price received on such sales.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 1 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Agent</b>&#8221; has the meaning set forth in the introductory paragraph of this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Agent Expenses</b>&#8221; has the meaning set forth in Section&#160;9.02.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Agreement</b>&#8221; has the meaning set forth in the introductory paragraph of this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Applicable Time</b>&#8221; means the time of sale of any Common Shares pursuant to this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Closing</b>&#8221; has the meaning set forth in Section&#160;2.02.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Closing Date</b>&#8221; means the date on which the Closing occurs.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Code</b>&#8221; has the meaning set forth in Section&#160;3.23.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Comfort Letter Triggering Event</b>&#8221; has the meaning set forth in Section&#160;4.08.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Commission</b>&#8221; means the United States Securities and Exchange Commission.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Commitment Period</b>&#8221; means the period commencing on the date of this Agreement and expiring on the earliest to occur of (x)&#160;the date on
    which the Agents in the aggregate shall have sold Common Shares having an aggregate gross sales price of the Maximum Program Amount pursuant to this Agreement, and (y)&#160;the date on which this Agreement is terminated pursuant to Article&#160;VII.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Common Shares</b>&#8221; shall mean shares of the Common Stock issued or issuable pursuant to this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Common Stock</b>&#8221; has the meaning set forth in the Recitals.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Company</b>&#8221; has the meaning set forth in the introductory paragraph of this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Controlling Persons</b>&#8221; has the meaning set forth in Section&#160;6.01.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>EDGAR</b>&#8221; has the meaning set forth in Section&#160;4.03.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Effective Date</b>&#8221; has the meaning set forth in Section&#160;3.03.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Exchange Act</b>&#8221; means the Securities Exchange Act of 1934, as amended.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Expenses</b>&#8221; has the meaning set forth in Section&#160;9.02.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>FCPA</b>&#8221; has the meaning set forth in Section&#160;3.26.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 2 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Floor Price</b>&#8221; means the minimum price per share set by the Company in the Issuance Notice below which the applicable Agent shall not sell
    Common Shares during the applicable Selling Period, which may be adjusted by the Company at any time during the applicable Selling Period and which in no event shall be less than $1.00 without the prior written consent of the applicable Agent, which
    may be withheld in such Agent&#8217;s sole discretion.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>General Disclosure Package</b>&#8221; has the meaning set forth in Section&#160;3.03.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Incorporated Documents</b>&#8221; has the meaning set forth in Section&#160;3.02.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Indemnified Party</b>&#8221; has the meaning set forth in Section&#160;6.03.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Indemnifying Party</b>&#8221; has the meaning set forth in Section&#160;6.03.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Issuance</b>&#8221; means each occasion on which the Company elects to exercise its right to deliver an Issuance Notice requiring the applicable
    Agent to use its commercially reasonable efforts to sell the Common Shares as specified in such Issuance Notice, subject to the terms and conditions of this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Issuance Amount</b>&#8221; means the aggregate gross sales price of Common Shares to be sold by an Agent with respect to any Issuance, subject to
    the conditions specified in Section 2.03(a) hereof.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Issuance Date</b>&#8221; means any Trading Day during the Commitment Period on which an Issuance Notice is deemed delivered pursuant to
    Section&#160;2.03(b) hereof.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Issuance Notice</b>&#8221; means a written notice to an Agent delivered in accordance with this Agreement substantially in the form attached hereto
    as Exhibit&#160;A.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Issuance Price</b>&#8221; means the Sales Price less the Selling Commission.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Issuance Shares</b>&#8221; means all shares of Common Stock issued or issuable pursuant to an Issuance that has occurred or may occur in accordance
    with the terms and conditions of this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Issuance Supplement</b>&#8221; has the meaning set forth in Section&#160;3.01.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Issuer Free Writing Prospectus</b>&#8221; means any &#8220;written communication&#8221; which constitutes a &#8220;free writing prospectus,&#8221; as such terms are defined
    in Rule&#160;405 under the Securities Act with respect to the offering of Common Shares contemplated by this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>IT Systems and Data</b>&#8221; has the meaning set forth in Section&#160;3.29.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Material Adverse Effect</b>&#8221; means a material adverse effect on the business, assets, operations, properties, prospects or condition
    (financial or otherwise) of the Company and its subsidiaries, taken as a whole, or any material adverse effect on the Company&#8217;s ability to consummate the transactions contemplated by, or to execute, deliver and perform its obligations under, this
    Agreement.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 3 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Maximum Program Amount</b>&#8221; means Seven Hundred Fifty Million Dollars ($750,000,000).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Money Laundering Laws</b>&#8221; has the meaning set forth in Section&#160;3.27.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>OECD Convention</b>&#8221; has the meaning set forth in Section&#160;3.26.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Officers&#8217; Certificate Triggering Event</b>&#8221; has the meaning set forth in Section&#160;4.09.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Opinion Triggering Event</b>&#8221; has the meaning set forth in Section&#160;4.07.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Original Registration Statement</b>&#8221; has the meaning set forth in Section&#160;3.01.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Permits</b>&#8221; has the meaning set forth in Section&#160;3.10.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Person</b>&#8221; means an individual or a corporation, partnership, limited liability company, trust, incorporated or unincorporated association,
    joint venture, joint stock company, governmental authority or other entity of any kind.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Principal Market</b>&#8221; means the New York Stock Exchange.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Principal Settlement Date</b>&#8221; has the meaning set forth in Section&#160;2.03.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Principal Transaction</b>&#8221; has the meaning set forth in Section&#160;2.01.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Prospectus</b>&#8221; has the meaning set forth in Section&#160;3.01.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Prospectus Supplement</b>&#8221; has the meaning set forth in Section&#160;5.01(k).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Registration Statement</b>&#8221; has the meaning set forth in Section&#160;3.01.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>REIT</b>&#8221; has the meaning set forth in Section&#160;3.22.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Representation Date</b>&#8221; has the meaning set forth in the introductory paragraph of Article&#160;III.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Sales Price</b>&#8221; means the actual sale execution price of each Issuance Share sold by an Agent on the Principal Market hereunder in the case
    of ordinary brokers&#8217; transactions, or as otherwise agreed by the parties hereto in other methods of sale.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Sanctioned country</b>&#8221; has the meaning set forth in Section&#160;3.28.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Sanctions</b>&#8221; has the meaning set forth in Section&#160;3.28.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Securities Act</b>&#8221; means the Securities Act of 1933, as amended.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Securities Act Regulations</b>&#8221; means the rules and regulations of the Commission under the Securities Act.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 4 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Selling Commission</b>&#8221; means the percentage (not to exceed 2%) of the Sales Price of Issuance Shares sold during a Selling Period as agreed
    from time to time by the Company and the applicable Agent; <b>provided, however, that</b> such commission shall not apply when an Agent acts as principal, in which case a different commission or a discount may be set forth in the applicable Terms
    Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Selling Period</b>&#8221; means the period determined by the Company in the Company&#8217;s sole discretion and specified in the applicable Issuance
    Notice following the Trading Day on which an Issuance Notice is delivered or deemed to be delivered pursuant to Section&#160;2.03(b) hereof.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Settlement Date</b>&#8221; has the meaning set forth in Section&#160;2.03.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Significant Subsidiary</b>&#8221; has the meaning set forth in Section&#160;3.05.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Stand Off Period</b>&#8221; has the meaning set forth in Section&#160;4.10.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Subsidiary Partnerships</b>&#8221; has the meaning set forth in Section&#160;3.21.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Trading Day</b>&#8221; means any day which is a trading day on the Principal Market, other than a day on which trading is scheduled to close prior
    to its regular weekday closing time.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Terms Agreement</b>&#8221; has the meaning set forth in Section&#160;2.01.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="text-transform: uppercase">Article II</font><br>
    <br>
    ISSUANCE AND SALE OF COMMON STOCK</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.01<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Issuance</b></font>.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subject to the terms and conditions set forth
    herein, the Company may issue and sell Common Shares through any Agent, acting as sales agent for the Company, or directly to any Agent(s), acting as principal, from time to time and on the terms and subject to conditions set forth in this Agreement
    and, in the case of a sale of Common Shares to any Agent(s) as principal, the applicable Terms Agreement, until the aggregate gross sales price of the Common Shares sold under this Agreement and any Terms Agreement (as defined below) equals the Maximum
    Program Amount or this Agreement is otherwise terminated. Subject to the foregoing and the other terms and conditions of this Agreement, upon the delivery of an Issuance Notice, and unless the sale of the Issuance Shares described therein has been
    suspended, cancelled or otherwise terminated in accordance with the terms of this Agreement, the applicable Agent will use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such Issuance Shares up to the
    amount specified in such Issuance Notice into the Principal Market, and otherwise in accordance with the terms of such Issuance Notice. Each Agent will provide written confirmation to the Company no later than the opening of the Trading Day next
    following the Trading Day on which it has made sales of Issuance Shares hereunder setting forth the portion of the Actual Sold Amount for such Trading Day, the corresponding Sales Price and the Issuance Price payable to the Company in respect thereof.
    Each Agent may sell Issuance Shares in the manner described in Section&#160;2.01(b) herein. In acting hereunder, an Agent will be acting as agent for the Company and not as principal; <b>provided, however, that</b> the Company may also offer to sell the
    Common Shares directly to an Agent, as principal, in which event such parties shall enter into a separate agreement (each, a &#8220;<b>Terms Agreement</b>&#8221;) in substantially the form of Exhibit A-1 hereto (with such changes thereto as may be agreed upon by
    the Company and such Agent to accommodate a transaction involving more than one Agent), relating to such sale in accordance with this Agreement (each such transaction being referred to as a &#8220;<b>Principal Transaction</b>&#8221;). The Company acknowledges and
    agrees that (i)&#160;there can be no assurance that an Agent will be successful in selling Issuance Shares, (ii)&#160;such Agent will incur no liability or obligation to the Company or any other Person if it does not sell Issuance Shares for any reason other
    than a failure by such Agent to use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such Issuance Shares in accordance with this Section&#160;2.01, and (iii)&#160;no Agent shall be under any obligation to
    purchase Common Shares on a principal basis pursuant to this Agreement, except as may otherwise be specifically agreed by such Agent and the Company in a Terms Agreement.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 5 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Method of Offer and Sale</b>. The Common Shares
    may be offered and sold (1)&#160;in privately negotiated transactions (if and only if the parties hereto have so agreed in writing), (2)&#160;as block transactions, or (3)&#160;by any other method or payment permitted by law deemed to be an &#8220;at the market&#8221; offering
    as defined in Rule&#160;415 under the Securities Act, including sales made directly on the Principal Market or sales made to or through a market maker or through an electronic communications network. Nothing in this Agreement or any Terms Agreement shall be
    deemed to require either party to agree to the method of offer and sale specified in the preceding sentence and either party may withhold its consent thereto in such party&#8217;s sole discretion. The Company agrees that any offer to sell, any solicitation
    of an offer to buy, or any sales of Issuance Shares by the Company shall be effected by or through only one Agent on any single given day, but in no event by more than one Agent, and the Company shall in no event request more than one Agent to sell
    Common Shares on the same day.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Issuance Exercise</b>. Upon the terms and subject
    to the conditions set forth herein, on any Trading Day, as provided in Section&#160;2.03(b) hereof, during the Commitment Period, on which the conditions set forth in Sections&#160;5.01 and 5.02 hereof have been satisfied, the Company may exercise an Issuance by
    the delivery of an Issuance Notice, executed by the Chief Executive Officer, the Chief Financial Officer, any Executive Vice President or any Senior Vice President of the Company, to an Agent. Such Agent shall use its commercially reasonable efforts to
    sell pursuant to such Issuance Notice a number of Common Shares having an aggregate gross sales price equal to the Issuance Amount set forth in the Issuance Notice; <b>provided that</b> such Agent shall not sell any fractional shares to reach the
    exact Issuance Amount and, if the sale of such fractional shares would be necessary to reach the Issuance Amount set forth in the Issuance Notice, such Agent shall only sell the maximum number of whole shares of Common Stock having an aggregate gross
    sales price that does not exceed the Issuance Amount set forth in the Issuance Notice. Each Issuance will be settled on the applicable Agency Settlement Date following the Issuance Date.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.02<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Effectiveness</b></font>. The effectiveness of this Agreement (the &#8220;<b>Closing</b>&#8221;) shall be deemed to take place concurrently with the execution and delivery of this Agreement by the parties hereto and the completion of the closing
    transactions set forth in the immediately following sentence; <b>provided that</b> such effectiveness shall continue through the filing and subsequent effectiveness of any further registration statements by the Company for the purpose of continuing
    the offering of the Common Shares upon expiration of the effectiveness of the Original Registration Statement after the third anniversary of its original effective date. At the Closing, the following closing transactions shall take place, each of which
    shall be deemed to occur simultaneously with the Closing: (i)&#160;the Company shall deliver to the Agents a certificate executed by the Secretary or an Assistant Secretary of the Company, signing in such capacity, dated the Closing Date (A)&#160;certifying that
    attached thereto are true and complete copies of the resolutions duly adopted by the Board of Directors of the Company or a duly authorized committee thereof authorizing the execution and delivery of this Agreement and the consummation of the
    transactions contemplated hereby (including, without limitation, the issuance of the Common Shares pursuant to this Agreement), which authorization shall be in full force and effect on and as of the date of such certificate and (B)&#160;certifying and
    attesting to the office, incumbency, due authority and specimen signatures of each Person who executed the Agreement for or on behalf of the Company; (ii)&#160;the Company shall deliver to the Agents a certificate executed by the Chief Executive Officer,
    the President, any Executive Vice President or any Senior Vice President of the Company and by the Chief Financial Officer of the Company, signing in such respective capacities, dated the Closing Date, confirming that the representations and warranties
    of the Company contained in this Agreement are true and correct and that the Company has performed, in all material respects, all of its obligations hereunder to be performed on or prior to the Closing Date and as to the matters set forth in
    Section&#160;5.01(a) hereof; (iii)&#160;Goodwin Procter LLP, counsel to the Company, shall deliver to the Agents an opinion and negative assurance letter, dated the Closing Date and addressed to each Agent, substantially in the form of Exhibit&#160;B-1 attached
    hereto; (iv)&#160;Goodwin Procter LLP, tax counsel to the Company, shall deliver to the Agents a tax opinion, dated the Closing Date and addressed to each Agent, substantially in the form of Exhibit&#160;B-2 attached hereto; (v)&#160;KPMG LLP shall deliver to the
    Agents a letter, dated the Closing Date, in form and substance reasonably satisfactory to the Agents; and (vi)&#160;the Company shall pay the expenses set forth in Section&#160;9.02(ii), (iv) and (viii) hereof by wire transfer to the account designated by the
    Agents in writing prior to the Closing.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 6 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.03<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Mechanics of Issuances</b></font>.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Issuance Notice</b>. On any Trading Day during
    the Commitment Period, the Company may deliver an Issuance Notice to an Agent, subject to the satisfaction of the conditions set forth in Sections&#160;5.01 and 5.02; <b>provided</b>, <b>however</b>, <b>that</b> (1)&#160;the Issuance Amount for each Issuance
    as designated by the Company in the applicable Issuance Notice shall in no event exceed Seven Hundred Fifty Million Dollars ($750,000,000) without the prior written consent of such Agent, which may be withheld in such Agent&#8217;s sole discretion and
    (2)&#160;notwithstanding anything in this Agreement or any Terms Agreement to the contrary, such Agent shall have no further obligations with respect to any Issuance Notice if and to the extent the aggregate gross sales price of Issuance Shares sold
    pursuant thereto, together with the aggregate gross sales price of Common Shares previously sold under this Agreement or any Terms Agreement, shall exceed the Maximum Program Amount. The Company shall have the right, in its sole discretion, to amend at
    any time and from time to time any Issuance Notice by notice to any Agent and, if so notified, such Agent shall, as soon as practicable, modify its offers to sell consistent with any such amendment notice.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Delivery of Issuance Notice</b>. An Issuance
    Notice or any amendment thereto shall be deemed delivered on the Trading Day that it is received by email to the applicable persons set forth in Schedule 1 hereto and confirmed by the Company by telephone (including a voicemail message to the persons
    so identified), with the understanding that, with adequate prior written notice, an Agent may modify the list of such persons from time to time. No Issuance Notice or any amendment thereto may be delivered other than on a Trading Day during the
    Commitment Period.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 7 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Floor Price</b>. An Agent shall not sell Issuance
    Shares below the Floor Price during the applicable Selling Period and such Floor Price may be adjusted by the Company at any time during the applicable Selling Period upon notice to such Agent and confirmation by such Agent to the Company.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Trading Guidelines</b>. The Company hereby
    acknowledges and agrees that each Agent and its Affiliates may, subject to compliance with Regulation&#160;M under the Exchange Act and Section&#160;5 of the Securities Act, if applicable, make markets in the Common Stock or other securities of the Company, in
    connection with which they may buy and sell, as agent or principal, for long or short account, shares of Common Stock or other securities of the Company, at the same time such Agent is acting as agent pursuant to this Agreement; <b>provided</b>, <b>however</b>,
    <b>that</b> the Company shall not be deemed to have authorized or consented to any such purchases or sales by such Agent and its Affiliates.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Principal Transaction Issuance</b>. If the
    Company wishes to issue and sell the Common Shares pursuant to this Agreement on a principal basis to an Agent, it will notify the applicable Agent of the proposed terms of the Principal Transaction. If such, acting as principal, wishes to accept such
    proposed terms (which it may decline to do for any reason in its sole discretion) or, following discussions with the Company, wishes to accept amended terms, the Company and such Agent shall enter into a Terms Agreement setting forth the terms of such
    Principal Transaction. The terms set forth in a Terms Agreement shall not be binding on the Company or an Agent unless and until the Company and such Agent have each executed and delivered such Terms Agreement accepting all of the terms of such Terms
    Agreement. In the event of a conflict between the terms of this Agreement and the terms of a Terms Agreement, the terms of such Terms Agreement shall control. Each sale of the Common Shares to an Agent in a Principal Transaction shall be made in
    accordance with the terms of this Agreement and a Terms Agreement, which shall provide for the sale of such Common Shares to, and the purchase thereof by, such Agent. A Terms Agreement may also specify certain provisions relating to the reoffering of
    such Common Shares by such Agent. The commitment of an Agent to purchase the Common Shares pursuant to any Terms Agreement shall be deemed to have been made on the basis of the representations, warranties and agreements of the Company contained, and
    shall be subject to the terms and conditions set forth, in this Agreement and such Terms Agreement. Any such Terms Agreement shall specify the number of the Common Shares to be purchased by the applicable Agent pursuant thereto, the price to be paid to
    the Company for such Common Shares, any provisions relating to rights of, and default by, underwriters, if any, acting together with such Agent in the reoffering of the Common Shares, and the time and date (each such time and date being referred to
    herein as a &#8220;<b>Principal Settlement Date</b>&#8221;; and, together with any Agency Settlement Date, as applicable, a &#8220;<b>Settlement Date</b>&#8221;) and place of delivery of and payment for such Common Shares. Notwithstanding anything to the contrary herein,
    nothing shall prohibit the Company from entering into a Terms Agreement with two or more Agents.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.04<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Settlements</b></font>. Subject to the provisions of Article&#160;V, on or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Issuance Shares being sold by crediting the
    applicable Agent or its designee&#8217;s account at The Depository Trust Company through its Deposit/Withdrawal At Custodian (DWAC) System, or by such other means of delivery as may be mutually agreed upon by the parties hereto and, upon receipt of such
    Issuance Shares, which in all cases shall be freely tradeable, transferable, registered shares in good deliverable form, such Agent will deliver the related Issuance Price in same day funds delivered to an account designated by the Company prior to the
    Settlement Date. If the Company defaults in its obligation to deliver Issuance Shares on a Settlement Date or as provided under a Terms Agreement, the Company agrees that it will (i)&#160;hold such Agent harmless against any loss, claim, damage or expense
    (including, without limitation, penalties, interest and reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the Company, and (ii)&#160;pay to such Agent any Selling Commission to which it would otherwise
    have been entitled absent such default. The parties hereto acknowledge and agree that, in performing its obligations under this Agreement, an Agent may borrow shares of Common Stock from stock lenders, and may use the Issuance Shares to settle or close
    out such borrowings.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 8 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.05<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Use of Free Writing Prospectus</b></font>. Neither the Company nor any Agent has prepared, used, referred to or distributed, or will prepare, use, refer to or distribute any Issuer Free Writing Prospectus without the other party&#8217;s
    prior written consent.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.06<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160; &#160; &#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Material Non-Public Information</b></font>. Notwithstanding any other provision of this Agreement or any Terms Agreement, an Agent shall not be obligated to sell any Common Shares hereunder during any period in which it reasonably
    believes that the Company is, or may be deemed to be, in possession of material non-public information.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.07<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Exemption from Regulation&#160;M</b></font>. If any party believes that the exemptive provisions set forth in Rule&#160;101(c)(1) of Regulation&#160;M under the Exchange Act (applicable to securities with an average daily trading volume value of at
    least $1,000,000 that are issued by an issuer whose common equity securities have a public float value of at least $150,000,000) are not satisfied with respect to the Company or the Common Shares, it shall promptly notify the other party and sales of
    Common Shares under this Agreement shall be suspended until that or other exemptive provisions have been satisfied in the reasonable judgment of all parties.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="text-transform: uppercase">Article III</font><br>
    <br>
    REPRESENTATIONS AND WARRANTIES OF THE COMPANY</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company represents and warrants to, and agrees with, each Agent that as of the Closing Date, as of each Issuance Date, as of each execution
    and delivery of a Terms Agreement by the Company, as of each applicable Settlement Date, and as of any time that the Registration Statement or the Prospectus shall be amended or supplemented (each of the times referenced above is referred to herein as
    a &#8220;<b>Representation Date</b>&#8221;), except as may be disclosed in the Prospectus (including any documents incorporated by reference therein and any supplements thereto) on or before a Representation Date:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.01<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Registration</b></font>. The Common Stock is registered pursuant to Section&#160;12(b) of the Exchange Act and is currently listed and quoted on the Principal Market under the trading symbol &#8220;EGP,&#8221; and the Common Shares have been or will
    have been listed on the Principal Market prior to delivery of the first Issuance Notice hereunder, subject to notice of issuance. The Company (i)&#160;meets the requirements for the use of Form&#160;S-3 under the Securities Act and the rules and regulations
    thereunder for the registration of the transactions contemplated by this Agreement and (ii)&#160;has been subject to the requirements of Section&#160;12 of the Exchange Act and has timely filed all the material required to be filed pursuant to Sections&#160;13 and 14
    of the Exchange Act for a period of more than 12 calendar months (other than a report that is required solely pursuant to Items&#160;1.01, 1.02, 1.04, 2.03, 2.04, 2.05, 2.06, 4.02(a) or 5.02(e) of Form&#160;8-K).</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 9 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has filed with the Commission an automatic shelf registration statement on Form&#160;S-3 (Registration No. 333-268821) (the
    &#8220;<b>Original Registration Statement</b>&#8221;), which registration statement, as amended, became effective upon filing under Rule&#160;462(c) under the Securities Act, for the registration of an indeterminate number of shares of Common Stock and other securities
    under the Securities Act, and the offering thereof from time to time pursuant to Rule&#160;415 promulgated by the Commission under the Securities Act. Such registration statement (and any further registration statements that may be filed by the Company for
    the purpose of continuing the offering of the Common Shares upon expiration of the effectiveness of the Original Registration Statement after the third anniversary of its original effective date or for the purpose of registering additional Common
    Shares to be sold pursuant to this Agreement), and the prospectus constituting part of such registration statement, together with the Prospectus Supplement (as defined in Section&#160;5.01(k)) and any pricing supplement relating to a particular issuance of
    the Issuance Shares (each, an &#8220;<b>Issuance Supplement</b>&#8221;) or a final pricing supplement relating to offering of the Common Shares by an Agent as principal pursuant to a Terms Agreement, including all documents incorporated or deemed to be
    incorporated therein by reference pursuant to Item&#160;12 of Form&#160;S-3 under the Securities Act, in each case, as from time to time amended or supplemented, are referred to herein as the &#8220;<b>Registration Statement</b>&#8221; and the &#8220;<b>Prospectus</b>,&#8221;
    respectively, except that if any revised prospectus is provided to the Agents by the Company for use in connection with the offering of the Common Shares that is not required to be filed by the Company pursuant to Rule&#160;424(b) promulgated by the
    Commission under the Securities Act, the term &#8220;Prospectus&#8221; shall refer to such revised prospectus from and after the time it is first provided to the Agents for such use. Promptly after the execution and delivery of this Agreement, the Company will
    prepare and file the Prospectus Supplement relating to the Issuance Shares pursuant to Rule&#160;424(b) promulgated by the Commission under the Securities Act, as contemplated by Section&#160;5.01(k) of this Agreement. As used in this Agreement, the terms
    &#8220;amendment&#8221; or &#8220;supplement&#8221; when applied to the Registration Statement or the Prospectus shall be deemed to include the filing by the Company with the Commission of any document under the Exchange Act after the date hereof that is or is deemed to be
    incorporated therein by reference.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is in compliance with the rules of the Principal Market, including, without limitation, the requirements for continued listing of the
    Common Shares on the Principal Market, and the Company has not received any notice from the Principal Market regarding the delisting of the Common Shares from the Principal Market.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.02<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Incorporated Documents</b></font>. The documents incorporated or deemed to be incorporated by reference in the Registration Statement, the Prospectus and the General Disclosure Package pursuant to Item&#160;12 of Form&#160;S-3 (collectively,
    the &#8220;<b>Incorporated Documents</b>&#8221;), as of the date filed with the Commission under the Exchange Act, comply in all material respects to the requirements of the Exchange Act and the rules and regulations of the Commission promulgated as applicable,
    and none of such documents contain an untrue statement of a material fact or omitted or will omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 10 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.03<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Registration Statement; Prospectus and Disclosure Package</b></font>. No stop order suspending the effectiveness of the Registration Statement has been issued and, to the knowledge of the Company, no proceeding for that purpose has
    been initiated or threatened by the Commission. The Registration Statement, as of the Effective Date, conformed or will conform in all material respects to the requirements of the Securities Act, and the rules and regulations of the Commission
    promulgated thereunder and, as of the Effective Date, does not and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, and
    the Prospectus, as of its original issue date, as of the date of any filing of an Issuance Supplement thereto pursuant to Rule&#160;424(b) promulgated by the Commission under the Securities Act, as of each Applicable Time and as of the date of any other
    amendment or supplement thereto, conforms or will conform in all material respects to the requirements of the Securities Act and the rules and regulations of the Commission promulgated thereunder and, as of such respective dates, does not and will not
    contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; as of each Applicable Time and the Closing Date, as
    the case may be, neither (i)&#160;the Issuer Free Writing Prospectus(es), if any, issued at or prior to such Applicable Time, the Prospectus and the public offering price of the Common Shares offered thereby, all considered together (collectively, the &#8220;<b>General

      Disclosure Package</b>&#8221;), nor (ii)&#160;any individual Issuer Free Writing Prospectus(es), if any, when considered together with the General Disclosure Package, will contain any untrue statement of a material fact or omit to state a material fact required
    to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <b>provided</b>, <b>however</b>, <b>that</b> this representation and warranty shall not apply to
    any statements or omissions made in reliance upon and in conformity with information furnished in writing to the Company by an Agent expressly for use in the Prospectus. As used herein, with respect to the Registration Statement, the term &#8220;<b>Effective
      Date</b>&#8221; means, as of a specified time, the later of (i)&#160;the date that the Registration Statement or the most recent post-effective amendment thereto became or becomes effective under the Securities Act and (ii)&#160;the date that the Company&#8217;s Annual
    Report on Form&#160;10-K for its most recently completed fiscal year is filed with the Commission under the Exchange Act.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.04<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Changes</b></font>. Neither the Company nor any Significant Subsidiary has sustained since the date of the latest audited financial statements included or incorporated by reference in the Registration Statement, the Prospectus and
    the General Disclosure Package any material loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise
    than as set forth or contemplated in the Prospectus; and, since the respective dates as of which information is given in the Registration Statement, the Prospectus and the General Disclosure Package, (i)&#160;neither the Company nor any Significant
    Subsidiary has incurred any liabilities or obligations, direct or contingent, or entered into any transactions, not in the ordinary course of business, that are material to the Company and its Significant Subsidiaries and (ii)&#160;there has not been any
    material change in the capital stock, except for issuances of capital stock pursuant to the Company&#8217;s dividend reinvestment program, if any, and employee benefit plans, or long-term debt, other than the repayment of current maturities of long-term
    debt, of the Company or any Significant Subsidiary or any material adverse change, or any development involving a prospective material adverse change, in or affecting the business, assets, general affairs, management, financial position, prospects,
    shareholders&#8217; equity or results of operations of the Company and its Significant Subsidiaries, otherwise than as set forth or contemplated in the Prospectus.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 11 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.05<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Organizational Matters</b></font>. The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Maryland, with corporate power and authority to own or lease its
    properties and to conduct its business as described in the General Disclosure Package; the Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse
    Effect. Each significant subsidiary, as defined in Rule&#160;405 under the Securities Act, including, but not limited to, as of the date of this Agreement, EastGroup Properties, L.P., EastGroup Properties General Partners, Inc. and EastGroup Properties
    Holdings, Inc. (each a &#8220;<b>Significant Subsidiary</b>&#8221;), has been duly incorporated or formed and is validly existing as a corporation, partnership or limited liability company, as applicable, in good standing under the laws of its jurisdiction of
    incorporation or formation with corporate, partnership or limited liability company power and authority to own or lease its properties and conduct its business as described in the General Disclosure Package. Each Significant Subsidiary is duly
    qualified as a foreign corporation, partnership or limited liability company, as applicable, to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of
    property or the conduct of business, except where the failure to be duly incorporated or formed, validly existing, have such power or authority or be so qualified would not have a Material Adverse Effect.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.06&#160;&#160;&#160;<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: Times New Roman, Times, Serif"><b>Authorization; Enforceability</b></font>. The Company has the corporate power and authority to execute, deliver and perform the terms and provisions of this Agreement and any Terms Agreement and has taken all necessary corporate
    action to authorize the execution, delivery and performance by it of, and the consummation of the transactions to be performed by it contemplated by, this Agreement and any Terms Agreement. No other corporate proceeding on the part of the Company is
    necessary, and no consent of any shareholder in its capacity as such of the Company is required, for the valid execution and delivery by the Company of this Agreement or any Terms Agreement, and the performance and consummation by the Company of the
    transactions contemplated by this Agreement or any Terms Agreement to be performed by the Company. The Company has duly executed and delivered this Agreement. This Agreement and any Terms Agreement constitute the valid and binding obligation of the
    Company, enforceable against the Company in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and
    by general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law) and by limitations imposed by law and public policy on indemnification or exculpation.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.07<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Capitalization</b></font>. The Company has an authorized capitalization as set forth in the General Disclosure Package, and all of the issued shares of capital stock of the Company have been duly and validly authorized and issued and
    are fully paid and non-assessable; none of the outstanding shares of capital stock of the Company was issued in violation of the preemptive or other similar rights of any security holder of the Company; all of the issued shares of capital stock or
    other ownership interests of each Significant Subsidiary have been duly and validly authorized and issued and are fully paid and non-assessable; and all shares of capital stock or other ownership interests of each Significant Subsidiary (other than
    directors&#8217; qualifying shares) are owned directly or indirectly by the Company, free and clear of any liens, encumbrances or security interests, except as described in the General Disclosure Package. The Common Shares have been duly and validly
    authorized by all necessary corporate action on the part of the Company. When issued against payment therefor as provided in this Agreement and any Terms Agreement, the Common Shares will be validly issued, fully paid and nonassessable, free and clear
    of all preemptive rights, claims, liens, charges, encumbrances and security interests of any nature whatsoever, other than any of the foregoing created by an Agent. The capital stock of the Company, including the Common Shares, conforms to the
    description contained in the General Disclosure Package. Except as set forth in the General Disclosure Package, there are no outstanding options, warrants, conversion rights, subscription rights, preemptive rights, rights of first refusal or other
    rights or agreements of any nature outstanding to subscribe for or to purchase any shares of Common Stock of the Company or any other securities of the Company of any kind binding on the Company (except pursuant to dividend reinvestment, stock purchase
    or ownership, stock option, director or employee benefit plans) and there are no outstanding securities or instruments of the Company containing anti-dilution or similar provisions that will be triggered by the issuance of the Common Shares as
    described in this Agreement and any Terms Agreement. Except as set forth in the Prospectus, there are no restrictions upon the voting or transfer of any shares of the Common Stock pursuant to the Company&#8217;s Articles of Incorporation or bylaws. There are
    no agreements or other obligations (contingent or otherwise) that may require the Company to repurchase or otherwise acquire any shares of its Common Stock. No Person has the right, contractual or otherwise, to cause the Company to issue to it, or to
    register pursuant to the Securities Act, any shares of capital stock or other securities of the Company upon the filing of the Registration Statement or the issuance or sale of the Common Shares hereunder.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 12 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.08<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>No Conflicts</b></font>. The issuance and sale of the Common Shares, the compliance by the Company with all of the provisions of this Agreement and any Terms Agreement and the consummation of the transactions contemplated herein do
    not and will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the imposition of a lien or security interest under, any indenture, mortgage, deed of trust, loan
    agreement or other agreement or instrument to which the Company or any Significant Subsidiary is a party or by which the Company or any Significant Subsidiary is bound or to which any of the property or assets used in the conduct of the business of the
    Company or any Significant Subsidiary is subject, except as would not reasonably be expected to have a Material Adverse Effect, nor will such action result in any violation of the provisions of the Articles of Incorporation, bylaws or other
    organizational document of the Company or any Significant Subsidiary or, to the best of the Company&#8217;s knowledge, any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over the Company or any
    Significant Subsidiary or any of their properties; and no consent, approval, authorization, order, registration or qualification of or with any court or governmental agency or body is required for the consummation by the Company of the transactions
    contemplated by this Agreement or any Terms Agreement or in connection with the issuance and sale of the Common Shares hereunder, except such as have been, or will have been prior to the Closing Date, obtained under the Securities Act, and for such
    consents, approvals, authorizations, orders, registrations or qualifications as may be required under state securities or blue sky laws, as the case may be, and except in any case where the failure to obtain such consent, approval, authorization,
    order, registration or qualification would not reasonably be expected to have a Material Adverse Effect.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 13 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.09<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Legal Proceedings</b></font>. Other than as set forth in the General Disclosure Package, there are no legal or governmental proceedings pending to which the Company or any of its controlled subsidiaries is a party or of which any
    property of the Company or any of its controlled subsidiaries is the subject which, if determined adversely to the Company or any of its controlled subsidiaries, would individually or in the aggregate reasonably be expected to have a Material Adverse
    Effect and, to the best of the Company&#8217;s knowledge, no such proceedings are threatened or contemplated by governmental authorities or threatened by others.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.10<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: Times New Roman, Times, Serif"><b>Sale of Common Shares</b></font>. Immediately after any sale of Common Shares by the Company hereunder, the aggregate amount of Common Stock that has been issued and sold by the Company hereunder will not exceed the aggregate amount
    of Common Stock registered under the Registration Statement (in this regard, the Company acknowledges and agrees that an Agent shall have no responsibility for maintaining records with respect to the aggregate amount of Common Shares sold, or for
    otherwise monitoring the availability of Common Stock for sale, under the Registration Statement).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.11<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Permits</b></font>. Each of the Company and its Significant Subsidiaries has such permits, licenses, franchises and authorizations of governmental or regulatory authorities (the &#8220;<b>Permits</b>&#8221;) as are necessary to own its
    respective properties and to conduct its business in the manner described in the General Disclosure Package, except where the failure to obtain such permits would not reasonably be expected to have a Material Adverse Effect; to the best knowledge of
    the Company after due inquiry, the Company and each of its Significant Subsidiaries has fulfilled and performed all its material obligations with respect to such Permits, except where the failure to fulfill or perform any such obligation would not
    reasonably be expected to have a Material Adverse Effect; and no event has occurred that allows, or after notice or lapse of time would allow, revocation or termination of any material Permits or would result in any other material impairment of the
    rights of the holder of any such material Permits, subject in each case to such qualifications as may be set forth in the Prospectus.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.12<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: Times New Roman, Times, Serif"><b>Investment Company</b></font>. The Company is not, and after giving effect to the offering and sale of the Common Shares, will not be, an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended (the
    &#8220;<b>1940 Act</b>&#8221;).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.13<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Financial Condition; No Adverse Changes</b></font>.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The financial statements, together with related
    schedules and notes, included in, or incorporated by reference into, the Registration Statement and the Prospectus, present fairly in all material respects the consolidated financial position, results of operations and changes in financial position of
    the Company and its consolidated subsidiaries on the basis stated in the Registration Statement, the Prospectus and the General Disclosure Package at the respective dates or for the respective periods to which they apply; such statements and related
    schedules and notes have been prepared in accordance with generally accepted accounting principles consistently applied throughout the periods involved, except as disclosed therein; the other financial and statistical information and data included or
    incorporated by reference in the Registration Statement, the Prospectus and the General Disclosure Package are accurately presented and prepared on a basis consistent with such financial statements and the books and records of the Company and its
    consolidated subsidiaries; and all disclosures contained or incorporated by reference in the Registration Statement, the Prospectus or the General Disclosure Package regarding &#8220;non-GAAP financial measures&#8221; (as such term is defined by the rules and
    regulations of the Commission) comply with Regulation&#160;G of the Exchange Act and Item&#160;10 of Regulation&#160;S-K under the Securities Act, to the extent applicable. No other financial statements are required to be set forth or to be incorporated by reference
    in the Registration Statement, the Prospectus or the General Disclosure Package under the Securities Act.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 14 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and its consolidated subsidiaries
    maintain systems of internal control over financial reporting (as such term is defined in Rule&#160;13a-15(f) under the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their
    respective principal executive and principal financial officers, or persons performing similar functions, sufficient to provide reasonable assurance that (i)&#160;transactions are executed in accordance with management&#8217;s general or specific authorizations;
    (ii)&#160;transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain accountability for assets; (iii)&#160;access to assets is permitted only in accordance with
    management&#8217;s general or specific authorization; (iv)&#160;the recorded accounting for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (v)&#160;material information relating to
    the Company and its subsidiaries is made known to the Company by its officers and employees. Other than as set forth in the General Disclosure Package, based on the Company&#8217;s most recent evaluation of its internal controls over financial reporting
    pursuant to Rule&#160;13a-15(c) of the Exchange Act, the Company concluded that its internal controls were effective and there are no material weaknesses. Since the date of the latest audited financial statements included or incorporated by reference in the
    Registration Statement, the Prospectus or the General Disclosure Package, there has been no change that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting, other than as set
    forth in the General Disclosure Package.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company maintains disclosure controls and
    procedures (as such term is defined in Rule&#160;13a-15(e) of the Exchange Act) that comply with the requirements of the Exchange Act and that have been designed to ensure that information required to be disclosed by the Company in reports that it files or
    submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&#8217;s rules and forms, including controls and procedures designed to ensure that such information is accumulated and
    communicated to the Company&#8217;s management as appropriate to allow timely decisions regarding required disclosure. The Company has carried out evaluations of the effectiveness of its disclosure controls and procedures as required by Rule&#160;13a-15 of the
    Exchange Act. Other than as set forth in the General Disclosure Package, based on the Company&#8217;s most recent evaluation of its disclosure controls and procedures pursuant to Rule&#160;13a-15 of the Exchange Act, the Company&#8217;s disclosure controls and
    procedures were effective. Other than as set forth in the General Disclosure Package, since the date of the most recent evaluation of such disclosure controls and procedures, there have been no significant changes to the Company&#8217;s disclosure controls
    and procedures; the Company, its subsidiaries and the Company&#8217;s directors and officers are each in compliance in all material respects with all applicable effective provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations of the
    Commission and the Principal Market promulgated thereunder.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 15 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>KPMG LLP, who has audited the financial statements
    of the Company and its consolidated subsidiaries that are incorporated by reference in the Registration Statement, the Prospectus and the General Disclosure Package and has audited the effectiveness of the Company&#8217;s internal control over financial
    reporting, is an independent registered public accounting firm as required by the Securities Act and the rules and regulations of the Commission promulgated thereunder and the Public Company Accounting Oversight Board.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The interactive data in eXtensible Business
    Reporting Language included or incorporated by reference in the Registration Statement and the General Disclosure Package presents fairly the information called for in all material respects and has been prepared in accordance with the Commission&#8217;s
    rules and guidelines applicable thereto.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>None of the Company&#8217;s subsidiaries are currently
    prohibited, directly or indirectly, from paying any dividends to the Company, from making any other distribution on such subsidiary&#8217;s capital stock, from repaying to the Company any loans or advances to such subsidiary from the Company or from
    transferring any of such subsidiary&#8217;s property or assets to the Company or any other subsidiary of the Company, except as described in the Registration Statement (excluding the exhibits thereto) and the Prospectus.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.14<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Use of Proceeds</b></font>. The Company will use the net proceeds from the offering of Common Shares in the manner specified in the General Disclosure Package under &#8220;Use of Proceeds.&#8221;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.15<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: Times New Roman, Times, Serif"><b>Environmental Matters</b></font>. Other than as set forth in the General Disclosure Package, (a)&#160;the Company and its controlled subsidiaries are in compliance with all applicable state and federal environmental laws, except for
    instances of noncompliance that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect, and (b)&#160;no event or condition has occurred that may interfere with the compliance by the Company and its controlled
    subsidiaries with any environmental law or that may give rise to any liability under any environmental law, in each case that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.16<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: Times New Roman, Times, Serif"><b>Insurance</b></font>. Each of the Company and its controlled subsidiaries is insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as management of the Company believes to be
    prudent and as are customary in the businesses in which they are engaged.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.17<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Officer&#8217;s Certificate</b></font>. Any certificate signed by any officer of the Company and delivered to the Agents or to counsel for the Agents in connection with an Issuance shall be deemed a representation and warranty by the
    Company to the Agents as to the matters covered thereby on the date of such certificate.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.18<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Finder&#8217;s Fees</b></font>. The Company has not incurred (directly or indirectly) nor will it incur, directly or indirectly, any liability for any broker&#8217;s, finder&#8217;s, financial advisor&#8217;s or other similar fee, charge or commission in
    connection with this Agreement or any Terms Agreement or the transactions contemplated hereby.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 16 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.19<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Non-affiliated Market Capitalization</b></font>. As of the Effective Date, the aggregate market value of the voting stock held by non-affiliates of the Company (computed using the price at which the Common Stock was last sold as of a
    date within 60&#160;days prior to such date) exceeds $150&#160;million.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.20<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Taxes</b></font>. The Company and its subsidiaries have filed all necessary federal, state and foreign income and franchise tax returns and paid all taxes shown as due thereon; all such tax returns are complete and correct in all
    material respects; all tax liabilities are adequately provided for on the books of the Company and its subsidiaries except to such extent as would not reasonably be expected to have a Material Adverse Effect; the Company and its subsidiaries have made
    all necessary tax payments (including payroll and/or withholding taxes) and are current and up-to-date; and the Company and its subsidiaries have no knowledge of any tax proceeding or action pending or threatened against the Company or its subsidiaries
    which, individually or in the aggregate, may reasonably be expected to have a Material Adverse Effect. The Company has made adequate charges, accruals and reserves in the applicable financial statements referred to in Section&#160;3.13 hereof in respect of
    all federal, state, local and foreign income and franchise taxes for all periods as to which the tax liability of the Company or any of the subsidiaries has not been finally determined.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.21<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Partnership Status</b></font>. Each of the Company&#8217;s subsidiaries that is a partnership or a limited liability company, other than any entity for which a taxable REIT subsidiary election has been made (&#8220;<b>Subsidiary Partnerships</b>&#8221;),

    is properly classified either as a disregarded entity or as a partnership, and not as a corporation or as an association taxable as a corporation, for federal income tax purposes throughout the period from which the Company acquired an interest in such
    Subsidiary Partnership through the date hereof, or, in the case of any Subsidiary Partnerships that have terminated, through the date of termination of such Subsidiary Partnerships.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.22<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>REIT Status</b></font>. With respect to all tax periods regarding which the Internal Revenue Service is or will be entitled to assert any claim that the Company has failed to qualify as a real estate investment trust, the Company has
    met the requirements for qualification as a real estate investment trust under Sections&#160;856 through 860 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), and the Company&#8217;s present and contemplated operations will allow it to continue to
    meet such requirements.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.23<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>REIT Compliance</b></font>. KPMG LLP (i)&#160;periodically tests procedures and conducts annual compliance reviews designed to determine compliance with the REIT provisions of the Code and (ii)&#160;assists the Company in monitoring what it
    believes are appropriate accounting systems and procedures designed to determine compliance with the REIT provisions of the Code.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.24<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Tax Disclosure</b></font>. The statements under the caption &#8220;Certain United States Federal Income Tax Considerations&#8221; in the General Disclosure Package are accurate in all material respects.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 17 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.25<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Actively-Traded Security</b></font>. Except under circumstances where either party has provided the other party with the notice required pursuant to Section&#160;2.07 of this Agreement, the Common Stock is an &#8220;actively-traded security&#8221;
    exempted from the requirements of Rule&#160;101 of Regulation&#160;M under the Exchange Act by subsection&#160;(c)(1) of such rule.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.26<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Anti-Bribery; Anti-Corruption</b></font>. Neither the Company or any of its subsidiaries nor, to the knowledge of the Company, any director, partner, officer, agent, employee or other person associated with or acting on behalf of the
    Company or any of its subsidiaries has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or
    authorization of any direct or indirect unlawful payment, benefit, or anything of value, to any foreign or domestic government official or employee, including of any government-owned or controlled entity or of a public international organization, or
    any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office to influence official action or secure an improper advantage; or (iii) violated or is in
    violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the &#8220;<b>FCPA</b>&#8221;), or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign
    Public Officials in International Business Transactions and the laws and regulations thereunder (the &#8220;<b>OECD Convention</b>&#8221;) or committed an offence under the Bribery Act 2010 of the United Kingdom, or any other applicable anti bribery or anti
    corruption law. The Company and its subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce, policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance
    with the FCPA, the OECD Convention or any other applicable anti bribery or anti corruption law or the rules and regulations thereunder. The Company and its subsidiaries will not, directly or indirectly, use the proceeds from the sale of the Common
    Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person, to fund, finance or facilitate activities, business or transactions that are prohibited by the FCPA, the OECD
    Convention or any other applicable anti bribery or anti corruption law or the rules and regulations thereunder.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.27<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Money Laundering</b></font>. The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign
    Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions, and the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any
    applicable governmental agency (collectively, the &#8220;<b>Money Laundering Laws</b>&#8221;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with
    respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.28<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Sanctions</b></font>. Neither the Company nor any of its subsidiaries, directors or officers, nor, to the knowledge of the Company based on reasonable inquiry, any employee, agent or affiliate of the Company or any of its
    subsidiaries is currently the subject of any U.S. economic or financial sanctions administered or enforced by the U.S. Government (including any administered or enforced by the Office of Foreign Assets Control of the U.S. Treasury Department, which
    includes the U.S. Government&#8217;s designation of such entities and persons as a &#8220;specially designated national&#8221; or a &#8220;blocked person&#8221;, the U.S. Department of Commerce, and/or the U.S. Department of State), the United Nations Security Council, the European
    Union, Her Majesty&#8217;s Treasury, or other relevant sanctions authority (collectively, &#8220;<b>Sanctions</b>&#8221;), nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is, or where the government is, the
    subject or target of Sanctions, including, without limitation, the Crimea Region of Ukraine, the so-called Donetsk People&#8217;s Republic or so-called Luhansk People&#8217;s Republic regions of Ukraine, Cuba, Iran, North Korea and Syria (each, a &#8220;<b>Sanctioned
      Country</b>&#8221;). The Company will not, directly or indirectly, use the proceeds from the sale of the Common Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person, (i) to
    fund or facilitate any activities of or business with any person that, at the time of such funding, is the subject of Sanctions, or is in a Sanctioned Country, or (ii) in any other manner that will result in a violation by any person (including any
    person participating in the offering, whether as sales agent, underwriter, advisor, investor or otherwise) of Sanctions. For the past five years, the Company and its subsidiaries have not knowingly engaged in, are not currently knowingly engaged in,
    and will not knowingly engage in, any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject of Sanctions.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 18 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.29<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Cybersecurity</b></font>. Except as disclosed in the Registration Statement or the General Disclosure Package, (A)&#160; to the knowledge of the Company there has been no security breach or incident, unauthorized access or disclosure, or
    other compromise of the Company&#8217;s or its controlled subsidiaries&#8217; information technology and computer systems, networks, hardware or software storing &#8220;personal data&#8221; or &#8220;personally identifiable information,&#8221; as such terms are defined under applicable
    law (including such data and information of their respective customers or employees maintained, processed or stored by the Company and its controlled subsidiaries, and any such data processed or stored by service providers on behalf of the Company and
    its controlled subsidiaries) (collectively, &#8220;<b>IT Systems and Data</b>&#8221;); (B)&#160;neither the Company nor its controlled subsidiaries have been notified of, and have no knowledge of any event or condition that would reasonably be expected to result in,
    any security breach or incident, unauthorized access or disclosure or other compromise to their IT Systems and Data and (C)&#160;the Company and its controlled subsidiaries have implemented controls, policies, procedures, and technological safeguards
    consistent with industry practice to maintain and protect the integrity, continuous operation, redundancy and security of their IT Systems and Data reasonably consistent with industry standards and practices, or as required by applicable regulatory
    standards, except with respect to clauses&#160;(A) and (B), for any such security breach, incident, unauthorized access or disclosure or compromise as would not, individually or in the aggregate, have a Material Adverse Effect, or with respect to
    clause&#160;(C), where the failure to do so would not, individually or in the aggregate, have a Material Adverse Effect. The Company and its controlled subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments,
    orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and
    Data from unauthorized use, access, misappropriation or modification.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 19 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="text-transform: uppercase">Article IV</font><br>
    <br>
    COVENANTS</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company covenants and agrees during the term of this Agreement or any Terms Agreement with each Agent as follows:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.01<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Registration Statement and Prospectus</b></font>. The Company shall (i)&#160;make no amendment or supplement to the Registration Statement or the Prospectus (other than (x)&#160;an amendment or supplement relating solely to the issuance or
    offering of securities other than the Common Shares and (y)&#160;an amendment or supplement by means of a Current Report on Form&#160;8-K filed with the Commission under the Exchange Act and incorporated or deemed to be incorporated by reference in the
    Registration Statement or the Prospectus; <b>provided that</b> the Company will give prior written notice to each Agent of the intention to file such report and describe the subject matter to be included in such report as soon as reasonably
    practicable prior to the filing of such report) after the date of delivery of an Issuance Notice or of the execution and delivery of a Terms Agreement by the Company and prior to the applicable Settlement Date at any time prior to having afforded each
    Agent a reasonable opportunity to review and comment thereon; (ii)&#160;prepare, with respect to any Issuance Shares to be sold pursuant to this Agreement or any Terms Agreement, an Issuance Supplement with respect to such Common Shares in a form previously
    approved by each Agent and to file such Issuance Supplement pursuant to Rule&#160;424(b) promulgated by the Commission under the Securities Act within the time period required thereby and to deliver such number of copies of each Issuance Supplement to each
    exchange or market on which such sales were effected, in each case unless delivery and filing of such an Issuance Supplement is not required by applicable law or by the rules and regulations of the Commission; (iii)&#160;make no amendment or supplement to
    the Registration Statement or the Prospectus (other than (x)&#160;an amendment or supplement relating solely to the issuance or offering of securities other than the Common Shares issued or issuable pursuant to this Agreement or any Terms Agreement or
    (y)&#160;by means of an Annual Report on Form&#160;10-K, a Quarterly Report on Form&#160;10-Q, a Proxy Statement on Schedule&#160;14A, a Current Report on Form&#160;8-K or a Registration Statement on Form&#160;8-A or any amendments to any of the foregoing filed with the Commission
    under the Exchange Act and incorporated or deemed to be incorporated by reference into the Registration Statement or the Prospectus except to the extent required by Section&#160;4.01(i)) without having afforded each Agent a reasonable opportunity to review
    and comment thereon prior to filing; (iv)&#160;file within the time periods required by the Exchange Act all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section&#160;13(a), 13(c),
    14 or 15(d) of the Exchange Act for so long as the delivery of a prospectus is required under the Securities Act or under the blue sky or securities laws of any jurisdiction in connection with the offering or sale of the Common Shares, and during such
    same period advise each Agent, promptly after the Company receives notice thereof, of (A)&#160;the time when any amendment to the Registration Statement has been filed or has become effective or any supplement to the Prospectus or any amended Prospectus has
    been filed with the Commission, in each case relating to the Common Shares to be sold pursuant to this Agreement or any Terms Agreement, (B)&#160;the issuance by the Commission of any stop order or of any order preventing or suspending the use of any
    prospectus relating to such Common Shares, (C)&#160;the suspension of the qualification of such Common Shares for offering or sale in any jurisdiction, or the initiation or threatening of any proceeding for any such purpose, or (D)&#160;any request by the
    Commission for the amending or supplementing of the Registration Statement or the Prospectus or for additional information relating thereto, or the receipt of any comments from the Commission with respect to the Registration Statement or the Prospectus
    (including, without limitation, any Incorporated Documents) and (v)&#160;in the event of the issuance of any such stop order or of any such order preventing or suspending the use of any prospectus relating to the Common Shares or suspending any such
    qualification during a Selling Period, promptly use its commercially reasonable efforts to obtain the withdrawal of such order. If, immediately prior to the third anniversary of the filing of Original Registration Statement, any of the Common Shares
    remain unsold hereunder, the Company will, prior to such third anniversary, advise each Agent as to whether it intends to file (unless it has already done so), a new automatic shelf registration statement or shelf registration statement, as applicable,
    relating to the Common Shares and, if such registration statement is not an automatic shelf registration statement, will use its reasonable best efforts to cause such registration statement to be declared effective as soon as practicable, and will take
    all other reasonable actions necessary or appropriate to permit the offering and sale of Common Shares to continue as contemplated in the expired registration statement relating to such Common Shares and this Agreement or any Terms Agreement.
    References herein to the &#8220;Registration Statement&#8221; shall include such new automatic shelf registration statement or shelf registration statement, as applicable.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 20 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.02<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: Times New Roman, Times, Serif"><b>Blue Sky</b></font>. The Company shall use its commercially reasonable efforts to cause the Common Shares to be listed on the Principal Market and promptly from time to time to take such action as each Agent may reasonably request to
    cooperate with each Agent in the qualification of the Common Shares for offering and sale under the blue sky or securities laws of such jurisdictions within the United States of America and its territories as each Agent may reasonably request and to
    use its commercially reasonable efforts to comply with such laws so as to permit the continuance of sales and dealings therein for as long as may be necessary to complete the sale of the Common Shares; <b>provided</b>, <b>however</b>, <b>that</b> in
    connection therewith the Company shall not be required to qualify as a foreign corporation, to file a general consent to service of process or to subject itself to taxation in respect of doing business in any jurisdiction.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.03<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: Times New Roman, Times, Serif"><b>Copies of the Registration Statement and Prospectus</b></font>. The Company shall furnish the Agents with copies (which may be electronic copies) of the Registration Statement and each amendment thereto (other than an amendment by
    means of any document incorporated or deemed to be incorporated therein by reference and which is available on the Commission&#8217;s Electronic Data Gathering Analysis and Retrieval (&#8220;<b>EDGAR</b>&#8221;) system), and with copies of the Prospectus and each
    amendment or supplement thereto (other than an amendment by means of any document incorporated or deemed to be incorporated therein by reference and which is available on the EDGAR system) in the form in which it is filed with the Commission pursuant
    to the Securities Act or Rule&#160;424(b) promulgated by the Commission under the Securities Act, both in such quantities as the Agents may reasonably request from time to time; and, if the delivery of a prospectus is required under the Securities Act or
    under the blue sky or securities laws of any jurisdiction at any time on or prior to the applicable Settlement Date for any Selling Period in connection with the offering or sale of the Common Shares and if at such time any event has occurred as a
    result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they
    were made when such Prospectus is delivered, not misleading, or, if for any other reason it is necessary during such same period to amend or supplement the Prospectus or to file under the Exchange Act any document incorporated by reference in the
    Prospectus in order to comply with the Securities Act or the Exchange Act, the Company shall notify the Agents and request that the Agents suspend offers to sell Common Shares (and, if so notified, the Agents shall cease such offers as soon as
    practicable); and if the Company decides to amend or supplement the Registration Statement or the Prospectus as then amended or supplemented, the Company shall advise the Agents promptly by telephone (with confirmation in writing or email) and prepare
    and cause to be filed promptly with the Commission an amendment or supplement to the Registration Statement or the Prospectus as then amended or supplemented that will correct such statement or omission or effect such compliance; <b>provided</b>, <b>however</b>,
    <b>that</b> if during such same period the Agents are required to deliver a prospectus in respect of transactions in the Common Shares, the Company shall promptly prepare and file with the Commission such an amendment or supplement.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 21 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.04<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Rule&#160;158</b></font>. The Company shall make generally available to its holders of the Common Shares as soon as practicable, but in any event not later than 18&#160;months after the &#8220;effective date&#8221; (as defined in Rule&#160;158(c) promulgated
    by the Commission under the Securities Act) of the Registration Statement, an earnings statement of the Company and its consolidated subsidiaries (which need not be audited) complying with Section&#160;11(a) of the Securities Act and the rules and
    regulations of the Commission promulgated thereunder (including the option of the Company to file periodic reports in order to make generally available such earnings statement, to the extent that it is required to file such reports under Section&#160;13 or
    Section&#160;15(d) of the Exchange Act, pursuant to Rule&#160;158 promulgated by the Commission under the Securities Act).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.05<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Information</b></font>. Except where such reports, communications, financial statements or other information is available on the EDGAR system, the Company shall furnish to the Agents (in paper or electronic format) copies of all
    publicly available reports or other communications (financial or other) furnished generally to stockholders and filed with the Commission pursuant to the Exchange Act, and deliver to the Agents (in paper or electronic format) (i)&#160;promptly after they
    are available, copies of any publicly available reports and financial statements furnished to or filed with the Commission or the Principal Market or any other national securities exchange on which any class of securities of the Company is listed; and
    (ii)&#160;such additional publicly available information concerning the business and financial condition of the Company as the Agents may from time to time reasonably request (such financial statements to be on a consolidated basis to the extent the
    accounts of the Company and its subsidiaries are consolidated in reports furnished to its stockholders generally or to the Commission).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.06<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Representations and Warranties</b></font>. At each delivery of an Issuance Notice and each execution and delivery of a Terms Agreement by the Company and each delivery of Common Shares on the applicable Settlement Date (i)&#160;the
    Company shall be deemed to have affirmed to each Agent that the representations and warranties of the Company contained in or made pursuant to this Agreement or any Terms Agreement are true and correct as of the date of such Issuance Notice or of such
    Settlement Date, as the case may be, as though made at and as of each such date, except as may be disclosed in the General Disclosure Package (including any documents incorporated by reference therein and any supplements thereto), and (ii)&#160;the Company
    will undertake to advise each Agent if any of such representations and warranties will not be true and correct as of the Settlement Date for the Common Shares relating to such Issuance Notice, as though made at and as of each such date (except that
    such representations and warranties shall be deemed to relate to the Registration Statement and the Prospectus as amended and supplemented relating to such Common Shares).</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 22 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.07<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Counsel Letters</b></font>. Each time the Registration Statement or the Prospectus is filed, amended or supplemented (other than by means of (x)&#160;an amendment or supplement relating solely to the offering of securities other than the
    Common Shares issued or issuable pursuant to this Agreement or any Terms Agreement, (y)&#160;an Issuance Supplement or (z)&#160;a Current Report on Form&#160;8-K, unless filed during a Selling Period and reasonably requested by the Agents within 5&#160;days of the filing
    thereof with the Commission), including by means of an Annual Report on Form&#160;10-K or a Quarterly Report on Form&#160;10-Q filed with the Commission under the Exchange Act and incorporated or deemed to be incorporated by reference into the Prospectus (each
    such amendment or supplement an &#8220;<b>Opinion Triggering Event</b>&#8221;):</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company shall as soon as practicable thereafter
    furnish or cause to be furnished to the Agents a written opinion and negative assurance letter of Goodwin Procter LLP, counsel for the Company (or such other counsel selected by the Company and reasonably satisfactory to the Agents) to the effect set
    forth in Exhibit&#160;B-1 hereto, dated the date of delivery and in form reasonably satisfactory to the Agents; <b>provided that</b> in rendering such opinion and negative assurance letter, Goodwin Procter LLP (or such other counsel selected by the Company
    and reasonably satisfactory to the Agents) may reasonably rely upon representations and covenants of duly appointed officers of the Company and its subsidiaries (including, without limitation, any such representations, covenants or statements made in
    certificates provided by such officers to counsel) and may make such assumptions as are customary with commercial practices;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company shall as soon as practicable thereafter
    furnish or cause to be furnished to the Agents a written tax opinion of Goodwin Procter LLP, tax counsel for the Company (or such other tax counsel selected by the Company and reasonably satisfactory to the Agents) to the effect set forth in
    Exhibit&#160;B-2 hereto, dated the date of delivery and in form reasonably satisfactory to the Agents; <b>provided that</b> in rendering such tax opinion, Goodwin Procter LLP (or such other tax counsel selected by the Company and reasonably satisfactory to
    the Agents) may reasonably rely upon representations and covenants of duly appointed officers of the Company and its subsidiaries (including, without limitation, any such representations, covenants or statements made in certificates provided by such
    officers to counsel) and may make such assumptions as are customary with commercial practices; and</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Clifford Chance US LLP, counsel to the Agents, shall
    furnish to the Agents a negative assurance letter in form and substance reasonably satisfactory to the Agents <b>provided</b>, <b>however</b>, <b>that</b> the opinions and negative assurance letters required pursuant to this Section&#160;4.07 shall not
    be required unless and until such time as (i)&#160;the Company delivers an Issuance Notice, (ii)&#160;the Opinion Triggering Event occurs during a Selling Period or (iii)&#160;the Company files a Registration Statement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.08<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Comfort Letters</b></font>. Each time the Registration Statement or the Prospectus is filed, amended or supplemented, including by means of an Annual Report on Form&#160;10-K, a Quarterly Report on Form&#160;10-Q or a Current Report on
    Form&#160;8-K (but only a Current Report on Form&#160;8-K that contains financial statements of the Company filed with the Commission under the Exchange Act and incorporated or deemed to be incorporated by reference into the Prospectus), other than by an
    amendment or supplement relating solely to the offering of securities other than the Common Shares issued or issuable pursuant to this Agreement or any Terms Agreement, in any case to set forth financial information included in or derived from the
    Company&#8217;s financial statements or accounting records (each such amendment or supplement a &#8220;<b>Comfort Letter Triggering Event</b>&#8221;), the Company shall as soon as practicable thereafter cause each independent registered public accounting firm who has
    audited the financial statements of the Company included or incorporated by reference in the Registration Statement to furnish to the Agents a letter, dated the date of delivery, in form reasonably satisfactory to the Agents, of the same tenor as the
    letter referred to in Section&#160;5.01(g) hereof but modified to relate to the Registration Statement, the Prospectus and to the extent applicable, the General Disclosure Package (other than the offering price of any Common Shares) as amended or
    supplemented to the date of such letter, with such changes as may be necessary to reflect changes in the financial statements and other information derived from the accounting records of the Company, to the extent such financial statements and other
    information are available as of a date not more than three business days prior to the date of such letter; <b>provided</b>, <b>however</b>, <b>that</b>, with respect to any financial information or other matters, such letter may reconfirm as true
    and correct at such date as though made at and as of such date, rather than repeat, statements with respect to such financial information or other matters made in the letter referred to in Section&#160;5.01(g) hereof that was last furnished to such Agent; <b>provided</b>,
    <b>however</b>, <b>that</b> the Company shall not be obligated to deliver any such comfort letter unless and until such time as (i)&#160;the Company delivers an Issuance Notice, (ii)&#160;the Comfort Letter Triggering Event occurs during a Selling Period or
    (iii)&#160;the Company files a Registration Statement.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 23 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.09<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Officers&#8217; Certificate</b></font>. Each time the Registration Statement or the Prospectus is filed, amended or supplemented (other than by means of (x)&#160;an amendment or supplement relating solely to the offering of securities other
    than the Common Shares issued or issuable pursuant to this Agreement or any Terms Agreement, (y)&#160;an Issuance Supplement or (z)&#160;a Current Report on Form&#160;8-K, unless filed during a Selling Period and reasonably requested by the Agents within five days of
    the filing thereof with the Commission), including by means of an Annual Report on Form&#160;10-K or a Quarterly Report on Form&#160;10-Q filed with the Commission under the Exchange Act and incorporated or deemed to be incorporated by reference into the
    Prospectus (each such amendment or supplement an &#8220;<b>Officers&#8217; Certificate Triggering Event</b>&#8221;), the Company shall as soon as practicable thereafter furnish or cause to be furnished forthwith to the Agents a certificate, dated the date of delivery,
    in such form and executed by such officers of the Company as is reasonably satisfactory to the Agents, of the same tenor as the certificate referred to in Section&#160;2.02(ii) but modified to relate to the Registration Statement, the Prospectus and the
    General Disclosure Package (other than the offering price of any Common Shares) as amended and supplemented to such date; <b>provided</b>, <b>however</b>, <b>that</b> the Company shall not be obligated to deliver any such officers&#8217; certificate
    unless and until such time as (i)&#160;the Company delivers an Issuance Notice, (ii)&#160;the Officers&#8217; Certificate Triggering Event occurs during a Selling Period or (iii)&#160;the Company files a Registration Statement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.10<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Stand Off Agreement</b></font>. Without the written consent of the Agents, the Company will not, directly or indirectly, offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any shares of Common
    Stock or securities convertible into or exchangeable for Common Stock (other than Common Shares hereunder), warrants or any rights to purchase or acquire, Common Stock during the period beginning on the first (1 ) Trading Day immediately prior to the
    date on which any Issuance Notice is delivered to the Agents hereunder and ending on the first (1 ) Trading Day immediately following the Settlement Date with respect to Common Shares sold pursuant to such Issuance Notice (the &#8220;<b>Stand Off Period</b>&#8221;);

    <b>provided</b>, <b>however</b>, <b>that</b> such restriction will not be required in connection with the Company&#8217;s issuance or sale of (i)&#160;Common Stock, options to purchase shares of Common Stock or Common Stock issuable upon the exercise of options
    or other equity awards pursuant to any employee or director stock option, incentive or benefit plan, stock purchase or ownership plan or dividend reinvestment plan (but not shares subject to a waiver to exceed plan limits in its stock purchase plan) of
    the Company, (ii)&#160;Common Stock issuable upon conversion of securities or the exercise of warrants, options or other rights disclosed in the Company&#8217;s Commission filings and (iii)&#160;Common Stock issuable as consideration in connection with acquisitions of
    business, assets or securities of other Persons. Any lock-up provisions relating to a Principal Transaction shall be set forth in the applicable Terms Agreement.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 24 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.11&#160;&#160;<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Market Activities</b></font>. The Company will not, directly or indirectly, (i)&#160;take any action designed to cause or result in, or that constitutes or might reasonably be expected to constitute, the stabilization or manipulation of
    the price of any security of the Company to facilitate the sale or resale of the Common Shares or (ii)&#160;during the Stand Off Period, sell, bid for or purchase the Common Shares, or pay any person any compensation for soliciting purchases of the Common
    Shares other than the Agents.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.12<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>REIT Status</b></font>. The Company will use its best efforts to continue to meet the requirements for qualification as a REIT under Sections&#160;856 through 860 of the Code.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.13<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Maximum Program Amount</b></font>. The Company will promptly notify the Agents when Common Shares having an aggregate gross sales price equal to the Maximum Program Amount have been sold pursuant to this Agreement or any Terms
    Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.14<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Due Diligence</b></font>. The Company will cooperate timely with any reasonable due diligence review conducted by the Agents or their counsel from time to time in connection with the transactions contemplated by this Agreement
    or any Terms Agreement, including, without limitation, and upon reasonable notice, providing information and making available documents and appropriate corporate officers and the Company&#8217;s accountants, during regular business hours and at the Company&#8217;s
    principal offices, as such Agent may reasonably request.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 25 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="text-transform: uppercase">Article V</font><br>
    <br>
    CONDITIONS TO DELIVERY OF ISSUANCE NOTICES AND TO SETTLEMENT</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 5.01<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Conditions Precedent to the Right of the Company to Deliver an Issuance Notice and the Obligation of the Agents to Sell Common Shares During the Selling Period(s)</b></font>. The right of the Company to deliver an Issuance Notice or
    sell Common Shares to an Agent under any Terms Agreement hereunder is subject to the satisfaction, on the date of delivery of such Issuance Notice or execution and delivery of such Terms Agreement, and any obligation of the Agents to sell Common Shares
    under this Agreement during the applicable Selling Period or under any Terms Agreement shall be subject to the satisfaction, on the applicable Settlement Date, of each of the following conditions:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Effective Registration Statement and
      Authorizations</b>. The Registration Statement shall remain effective and sales of all of the Common Shares (including all of the Issuance Shares issued with respect to all prior Issuances and all of the Issuance Shares expected to be issued in
    connection with the Issuance specified by the current Issuance Notice) may be made by an Agent thereunder, and (i)&#160;no stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceeding for that purpose shall
    have been initiated or, to the Company&#8217;s knowledge, threatened by the Commission; (ii)&#160;no other suspension of the use or withdrawal of the effectiveness of the Registration Statement or Prospectus shall exist; (iii)&#160;all requests for additional
    information on the part of the Commission shall have been complied with to the reasonable satisfaction of the Agents and (iv)&#160;no event specified in Section&#160;4.03 hereof shall have occurred and be continuing without the Company amending or supplementing
    the Registration Statement or the Prospectus as provided in Section&#160;4.03. The authorizations referred to in Section&#160;3.08 of this Agreement shall have been issued and shall be in full force and effect, and such authorizations shall not be the subject of
    any pending or, to the Company&#8217;s knowledge, threatened application for rehearing or petition for modification, and are sufficient to authorize the issuance and sale of the Common Shares.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Accuracy of the Company&#8217;s Representations and
      Warranties</b>. The representations and warranties of the Company shall be true and correct as of the Closing Date, as of the applicable date referred to in Section&#160;4.09 that is prior to such Issuance Date or Settlement Date, as the case may be, and
    as of such Issuance Date and Settlement Date as though made at such time, or with respect to a Principal Transaction pursuant to a Terms Agreement, at the time of execution and delivery of the Terms Agreement by the Company and at the relevant Time of
    Sale (as set forth in the applicable Terms Agreement) and Settlement Date.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Performance by the Company</b>. The Company shall
    have performed, satisfied and complied, in all material respects, with all covenants, agreements and conditions required by this Agreement or any Terms Agreement to be performed, satisfied or complied with by the Company at or prior to such date.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>No Injunction</b>. No statute, rule, regulation,
    executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated
    hereby that prohibits or directly and materially adversely affects any of the transactions contemplated by this Agreement or any Terms Agreement, and no proceeding shall have been commenced that may have the effect of prohibiting or materially
    adversely affecting any of the transactions contemplated by this Agreement or any Terms Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Material Adverse Changes</b>. Since the date of
    this Agreement and any Terms Agreement, no event that had or is reasonably likely to have a Material Adverse Effect shall have occurred that has not been disclosed in the General Disclosure Package (including the documents incorporated by reference
    therein and any supplements thereto).</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 26 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"> <br>
  </p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>No Suspension of Trading In or Delisting of
      Common Stock; Other Events</b>. The trading of the Common Stock (including without limitation the Issuance Shares) shall not have been suspended by the Commission, the Principal Market or the Financial Industry Regulatory Authority since the
    immediately preceding Settlement Date or, if there has been no Settlement Date, the Closing Date, and the Common Shares (including without limitation the Issuance Shares) shall have been approved for listing or quotation on, subject to notice of
    issuance, and shall not have been delisted from the Principal Market. There shall not have occurred (and be continuing in the case of occurrences under clauses&#160;(i) and (ii) below) any of the following: (i)&#160;trading generally on the Principal Market or
    The Nasdaq Stock Market has been suspended or materially limited, or minimum and maximum prices for trading have been fixed, or maximum ranges for prices have been required, by either of said exchanges or by such system or by order of the Commission,
    the Financial Industry Regulatory Authority or any other governmental authority, or a material disruption has occurred in commercial banking or securities settlement or clearance services in the United States; (ii)&#160;a general moratorium on commercial
    banking activities in New York declared by either federal or New York state authorities; or (iii)&#160;any material adverse change in the financial markets in the United States or in the international financial markets, any outbreak or escalation of
    hostilities or other calamity or crisis involving the United States or the declaration by the United States of a national emergency or war or any change or development involving a prospective change in national or international political, financial or
    economic conditions, if the effect of any such event specified in this clause&#160;(iii) in the sole judgment of the Agents makes it impracticable or inadvisable to proceed with the sale of Common Shares.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"> <br>
  </p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Comfort Letter</b>. Each independent registered
    public accounting firm who has audited the financial statements included or incorporated by reference in the Registration Statement shall have furnished to the Agents a letter required to be delivered pursuant to Section&#160;4.08 on or before the date on
    which satisfaction of this condition is determined.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>No Defaults</b>. The execution and delivery of
    this Agreement and any Terms Agreement and the issuance and sale of the Common Shares and the compliance by the Company with all of the provisions of this Agreement and any Terms Agreement will not result in the Company or any of the Significant
    Subsidiaries being in default of (whether upon the passage of time, the giving of notice or both) their organizational and other governing documents, or any provision of any security issued by the Company or any of its Significant Subsidiaries, or of
    any agreement, instrument or other undertaking to which the Company or any of its Significant Subsidiaries is a party or by which it or any of its property or assets is bound, or the applicable provisions of any law, statute, rule, regulation, order,
    writ, injunction, judgment or decree of any court or governmental authority to or by which the Company, any of its Significant Subsidiaries or any of their property or assets is bound, in each case which default, either individually or in the
    aggregate, could reasonably be expected to have a Material Adverse Effect.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Trading Cushion</b>. The Selling Period for any
    previous Issuance Notice shall have expired or been terminated.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Maximum Issuance Amount</b>. In no event may
    the Company issue an Issuance Notice to sell an Issuance Amount to the extent that the sum of (x)&#160;the requested Issuance Amount, plus (y)&#160;the aggregate Issuance Amounts sold under all previous Issuances effected pursuant to this Agreement or any Terms
    Agreement, would exceed the Maximum Program Amount.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 27 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Prospectus Supplement and Issuance Supplement</b>.
    (i)&#160;A supplement to the prospectus included in the Registration Statement related to the offering and sale of Common Shares pursuant to this Agreement or any Terms Agreement (the &#8220;<b>Prospectus Supplement</b>&#8221;), in form and substance to be agreed upon
    by the parties hereto, setting forth information regarding this Agreement including, without limitation, the Maximum Program Amount, shall have been filed with the Commission pursuant to Rule&#160;424(b) promulgated by the Commission under the Securities
    Act within the time period required thereby and sufficient copies thereof delivered to the Agents on or prior to the Issuance Date; and (ii)&#160;to the extent required by Section&#160;4.01(ii), an Issuance Supplement, in form and substance to be agreed upon by
    the parties, shall have been filed with the Commission pursuant to Rule&#160;424(b) promulgated by the Commission under the Securities Act within the time period required thereby and sufficient copies thereof delivered to the Agents on or prior to the
    Issuance Date.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Counsel Letters</b>. (i)&#160;Goodwin Procter LLP (or
    other counsel selected by the Company and reasonably satisfactory to the Agents), shall have furnished to the Agents their written opinion and negative assurance letter required to be delivered pursuant to Section&#160;4.07(a) on or before the date on which
    satisfaction of this condition is determined; (ii)&#160;Goodwin Procter LLP (or other tax counsel selected by the Company and reasonably satisfactory to the Agents), shall have furnished to the Agents their written tax opinion required to be delivered
    pursuant to Section&#160;4.07(b) on or before the date on which satisfaction of this condition is determined; and (iii)&#160;Clifford Chance US LLP, counsel for the Agents, shall have furnished to the Agents the negative assurance letter required to be delivered
    pursuant to Section&#160;4.07(c) on or before the date on which satisfaction of this condition is determined.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Officers&#8217; Certificate</b>. The Company shall have
    furnished or caused to be furnished to the Agents an officers&#8217; certificate executed by the Chief Executive Officer, the President, any Executive Vice President or any Senior Vice President of the Company and by the Chief Financial Officer of the
    Company, signing in such respective capacities, required to be delivered pursuant to Section&#160;4.09 on or before the date on which satisfaction of this condition is determined, as to the matters specified in Section&#160;2.02(ii).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Chief Financial Officer&#8217;s Certificate</b>. The
    Company shall have furnished or caused to be furnished to the Agents an officer&#8217;s certificate executed by the Chief Financial Officer, satisfactory to the Agents, with respect to certain information contained in the Registration Statement, the
    Incorporated Documents and the General Disclosure Package.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Other Documents</b>. On the Closing Date and
    prior to each Issuance Date and Settlement Date, the Agents and their counsel shall have been furnished with such documents as they may reasonably require in order to evidence the accuracy and completeness of any of the representations or warranties,
    or the fulfillment of the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Common Shares as herein contemplated shall be reasonably satisfactory in form and substance to the Agents
    and their counsel.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 5.02<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Suspension of Sales</b></font>. The Company or each Agent may, upon notice to the other party hereto in writing, including by email, or by telephone (confirmed immediately by verifiable facsimile transmission), suspend any sale of
    Issuance Shares, and the applicable Selling Period shall immediately terminate; <b>provided</b>, <b>however</b>, <b>that</b> such suspension and termination shall not affect or impair either party&#8217;s obligations with respect to any Issuance Shares
    sold hereunder after a reasonably practicable period of time following receipt of such notice, but in no event shall there be any Issuance Shares sold beyond the trading day in which the notice was received. The Company agrees that no such notice shall
    be effective against any Agent unless it is made to one of the individuals named on Schedule&#160;1 hereto, as such Schedule may be amended from time to time. The Agents agree that no such notice shall be effective against the Company unless it is made to
    one of the individuals named on Schedule&#160;1 annexed hereto, as such Schedule may be amended from time to time.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 28 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="text-transform: uppercase">Article VI</font><br>
    <br>
    INDEMNIFICATION AND CONTRIBUTION</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.01<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: Times New Roman, Times, Serif"><b>Indemnification by the Company</b></font>. The Company agrees to indemnify and hold harmless each Agent, its officers, directors, employees and agents, and each Person, if any, who controls such Agent within the meaning of Section&#160;15
    of the Securities Act or Section&#160;20 of the Exchange Act, together with each such Person&#8217;s respective officers, directors, employees and agents (collectively, the &#8220;<b>Controlling Persons</b>&#8221;), and each affiliate of such Agent (within the meaning of
    Rule&#160;405 under the Securities Act Regulations), from and against any and all losses, claims, damages or liabilities, and any action or proceeding in respect thereof, to which such Agent, its officers, directors, employees and agents, and any such
    Controlling Person may become subject under the Securities Act, the Exchange Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) arise out of, or are based upon, any untrue statement
    or alleged untrue statement of a material fact contained in the Registration Statement, the Prospectus or any other prospectus relating to the Common Shares, or any amendment or supplement thereto, any preliminary prospectus, or any Issuer Free Writing
    Prospectus or any &#8220;issuer information&#8221; filed or required to be filed pursuant to Rule&#160;433(d) under the Securities Act, or arise out of, or are based upon, any omission or alleged omission to state therein a material fact required to be stated therein
    or necessary to make the statements therein (in the case of the Prospectus or any amendment or supplement thereto or any preliminary prospectus, or any Issuer Free Writing Prospectus, in light of the circumstances in which they were made) not
    misleading, except insofar as the same are made in reliance upon and in conformity with information related to the Agents or their plan of distribution furnished in writing to the Company by or on behalf of the Agents expressly for use therein, and the
    Company shall reimburse the Agents, its officers, directors, employees and agents, and each Controlling Person for any reasonable legal and other expenses incurred thereby in investigating or defending or preparing to defend against any such losses,
    claims, damages or liabilities, or actions or proceedings in respect thereof, as such expenses are incurred.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.02<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Indemnification by the Agents</b></font>. Each Agent agrees, severally and not jointly, to indemnify and hold harmless the Company, its officers, directors, employees and agents and each Person, if any, who controls the Company
    within the meaning of Section&#160;15 of the Securities Act or Section&#160;20 of the Exchange Act, together with each such Person&#8217;s respective officers, directors, employees and agents, and each affiliate of the Company (within the meaning of Rule&#160;405 under the
    Securities Act Regulations), from and against any losses, claims, damages or liabilities, and any action or proceeding in respect thereof, to which the Company, its officers, directors, employees or agents, any such controlling Person and any officer,
    director, employee or agent of such controlling Person may become subject under the Securities Act, the Exchange Act or otherwise, insofar as losses, claims, damages or liabilities (or action or proceeding in respect thereof) arise out of, or are based
    upon, any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Prospectus or any other prospectus relating to the Common Shares, or any amendment or supplement thereto, or any preliminary
    prospectus, or any Issuer Free Writing Prospectus, or arise out of, or are based upon, any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of the
    Prospectus or any other prospectus relating to the Common Shares, or any amendment or supplement thereto or any preliminary prospectus, or any Issuer Free Writing Prospectus, in light of the circumstances in which they were made) not misleading in each
    case to the extent, but only to the extent that such untrue statement or alleged untrue statement or omission or alleged omission was made therein in reliance upon and in conformity with written information related to the Agents or their plan of
    distribution furnished to the Company by or on behalf of the Agents expressly for use therein.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 29 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.03<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Conduct of Indemnification Proceedings</b></font>. Promptly after receipt by any Person (an &#8220;<b>Indemnified Party</b>&#8221;) of notice of any claim or the commencement of any action in respect of which indemnity may be sought pursuant to
    Section&#160;6.01 or 6.02, the Indemnified Party shall, if a claim in respect thereof is to be made against the Person against whom such indemnity may be sought (an &#8220;<b>Indemnifying Party</b>&#8221;), notify the Indemnifying Party in writing of the claim or the
    commencement of such action. In the event an Indemnified Party shall fail to give such notice as provided in this Section&#160;6.03 and the Indemnifying Party to whom notice was not given was unaware of the proceeding to which such notice would have related
    and was materially prejudiced by the failure to give such notice, the indemnification provided for in Section&#160;6.01 or 6.02 shall be reduced to the extent of any actual prejudice resulting from such failure to so notify the Indemnifying Party; <b>provided

      that</b> the failure to notify the Indemnifying Party shall not relieve it from any liability that it may have to an Indemnified Party otherwise than under Section&#160;6.01 or 6.02. If any such claim or action shall be brought against an Indemnified
    Party, the Indemnifying Party shall be entitled to participate therein, and, to the extent that it wishes, jointly with any other similarly notified Indemnifying Party, to assume the defense thereof with counsel reasonably satisfactory to the
    Indemnified Party. After notice from the Indemnifying Party to the Indemnified Party of its election to assume the defense of such claim or action, the Indemnifying Party shall not be liable to the Indemnified Party for any legal or other expenses
    subsequently incurred by the Indemnified Party in connection with the defense thereof other than reasonable costs of investigation; <b>provided that</b> the Indemnified Party shall have the right to employ separate counsel to represent the Indemnified
    Party, but the fees and expenses of such counsel shall be for the account of such Indemnified Party unless (i)&#160;the Indemnifying Party and the Indemnified Party shall have mutually agreed to the retention of such counsel or (ii)&#160;such Indemnified Party
    reasonably concludes that representation of both parties by the same counsel would be inappropriate due to actual or potential conflicts of interest with the Company, it being understood, however, that the Indemnifying Party shall not, in connection
    with any one such claim or action or separate but substantially similar or related claims or actions in the same jurisdiction arising out of the same general allegations or circumstances, be liable for the fees and expenses of more than one separate
    firm of attorneys (together with appropriate local counsel) at any time for all Indemnified Parties under this Agreement or for fees and expenses that are not reasonable. No Indemnifying Party shall, without the prior written consent of the Indemnified
    Party, effect any settlement of any claim or pending or threatened proceeding in respect of which the Indemnified Party is or could have been a party and indemnification could have been sought hereunder by such Indemnified Party unless such settlement
    (a)&#160;includes an unconditional release of each such Indemnified Party from all losses, claims, damages or liabilities arising out of such claim or proceeding, (b)&#160;involves only the payment of money, and (c)&#160;does not admit or constitute an admission of
    fault, guilt, failure to act or culpability on the part of any such Indemnified Party.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 30 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.04<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Contribution</b></font>. If for any reason the indemnification provided for in this Article&#160;VI is unavailable to the Indemnified Parties in respect of any losses, claims, damages or liabilities referred to herein, then each
    Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such losses, claims, damages or liabilities as between the Company, on the one hand, and the
    applicable Agents, on the other hand, in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the applicable Agents on the other hand from the offering of the Common Shares to which such losses,
    claims, damages or liabilities relate. If, however, the allocation provided by the immediately preceding sentence is not permitted by applicable law, then each Indemnifying Party shall contribute to such amount paid or payable by such Indemnifying
    Party in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company and the applicable Agents in connection with such statements or omissions, as well as any other relevant equitable
    considerations. The relative benefits received by the Company, on the one hand, and by the applicable Agents, on the other, shall be deemed to be in the same proportion as the total net proceeds from the sale of Common Shares (before deducting
    expenses) received by the Company bear to the total commissions received by the applicable Agents in respect thereof. The relative fault of the Company, on the one hand, and the applicable Agents, on the other hand, shall be determined by reference to,
    among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company on one hand or by the applicable Agents on the other hand,
    and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and the Agents agree that it would not be just and equitable if contribution pursuant to this Section&#160;6.04 were determined by <i>pro
      rata</i> allocation or by any other method of allocation that does not take account of the equitable considerations referred to in the immediately preceding paragraph. The amount paid or payable by an Indemnified Party as a result of the losses,
    claims, damages or liabilities referred to in the immediately preceding paragraph shall be deemed to include, subject to the limitations set forth above, any reasonable legal or other expenses reasonably incurred by such Indemnified Party in connection
    with investigating or defending any such action or claim. Notwithstanding the provisions of this Section&#160;6.04, no Agent shall in any event be required to contribute any amount in excess of the commissions received by such Agent under this Agreement or
    any Terms Agreement. No Person guilty of fraudulent misrepresentation (within the meaning of Section&#160;11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. For purposes of
    this Section&#160;6.04, each officer, director, employee and agent of an Agent, and each Controlling Person, shall have the same rights to contribution as such Agent, and each director of the Company, each officer of the Company who signed the Registration
    Statement, and each Controlling Person shall have the same rights to contribution as the Company. The obligations of the Company and the Agents under this Article&#160;VI are several and not joint and shall be in addition to any liability that the Company
    and the Agents may otherwise have.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 31 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="text-transform: uppercase">Article VII</font><br>
    <br>
    TERMINATION</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.01<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Term</b></font>. Subject to the provisions of this Article&#160;VII, the term of this Agreement shall run until the end of the Commitment Period.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.02<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Termination by an Agent</b></font>. Each Agent may terminate the right of the Company to effect any Issuances under this Agreement or any Terms Agreement, as to itself:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>upon one (1)&#160;Trading Day&#8217;s notice if any of the
    following events shall occur:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font>the Company or any Significant Subsidiary shall
    make an assignment for the benefit of creditors, or apply for or consent to the appointment of a receiver or trustee for it or for all or substantially all of its property or business; or such a receiver or trustee shall otherwise be appointed;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font>bankruptcy, insolvency, reorganization or
    liquidation proceedings or other proceedings for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Company or any of its Significant Subsidiaries;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font>the Company shall fail to maintain the listing of
    the Common Stock on the Principal Market;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font>since the Effective Date, there shall have occurred
    any event, development or state of circumstances or facts that has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; or</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font>upon ten (10)&#160;days&#8217; notice of its election to
    terminate this Agreement, in its sole discretion, at any time.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.03<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Termination by the Company</b></font>. The Company shall have the right, by giving ten (10)&#160;days&#8217; notice as hereinafter specified, to terminate this Agreement in its sole discretion at any time. After delivery of such notice, the
    Company shall no longer have any right to deliver any Issuance Notices hereunder. In the case of any sale by the Company pursuant to a Terms Agreement, the obligations of the Company pursuant to such Terms Agreement and this Agreement may not be
    terminated by the Company without the prior written consent of the applicable Agent.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.04<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Liability; Provisions that Survive Termination</b></font>. If this Agreement is terminated pursuant to this Article&#160;VII, such termination shall be without liability of any party hereto to any other party hereto except as provided in
    Section&#160;9.02 and for the Company&#8217;s obligations in respect of all prior Issuance Notices, and <b>provided</b>, <b>further</b>, <b>that</b> in any case the provisions of Article&#160;VI, this Section&#160;7.04, Article&#160;VIII and Article&#160;IX shall survive
    termination of this Agreement without limitation.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 32 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="text-transform: uppercase">Article VIII</font><br>
    <br>
    REPRESENTATIONS AND WARRANTIES TO SURVIVE DELIVERY</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All representations and warranties of the Company herein or in certificates delivered pursuant hereto shall remain operative and in full force and
    effect regardless of (i)&#160;any investigation made by or on behalf of each Agent and its officers, directors, employees and agents and any Controlling Persons, (ii)&#160;delivery and acceptance of the Common Shares and payment therefor or (iii)&#160;any termination
    of this Agreement and any Terms Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="text-transform: uppercase">Article IX</font><br>
    <br>
    MISCELLANEOUS</p>
  <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.01<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Press Releases and Disclosure</b></font>. The Company may issue a press release describing the material terms of the transactions contemplated hereby as soon as practicable following the Closing Date or the execution and delivery of
    any Terms Agreement, and may file with the Commission a Current Report on Form&#160;8-K describing the material terms of the transactions contemplated hereby, and the Company shall consult with the Agents prior to making such disclosures, and the parties
    hereto shall use all commercially reasonable efforts, acting in good faith, to agree upon a text for such disclosures that is reasonably satisfactory to all parties hereto. No party hereto shall issue thereafter any press release or like public
    statement (including, without limitation, any disclosure required in reports filed with the Commission pursuant to the Exchange Act) related to this Agreement or any Terms Agreement or any of the transactions contemplated hereby that has not been
    previously disclosed without the prior written approval of the other party hereto, which such approval will not unreasonably withheld, except as may be necessary or appropriate in the opinion of the party seeking to make disclosure to comply with the
    requirements of applicable law or stock exchange rules. If any such press release or like public statement is so required, the party making such disclosure shall consult with the other party prior to making such disclosure, and the parties shall use
    all commercially reasonable efforts, acting in good faith, to agree upon a text for such disclosure that is reasonably satisfactory to all parties hereto. Notwithstanding the foregoing, the Company may disclose the results of any Issuance, including
    the Issuance Price and number of shares of Common Stock issued pursuant to an Issuance and the entry into, or issuance of Common Shares pursuant to, a Terms Agreement in a press release, quarterly report on Form&#160;10-Q or annual report on Form&#160;10-K and
    the Company may provide oral updates of such previously publicly disclosed information to investors and/or shareholders without the prior written approval of the Agents.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.02<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: Times New Roman, Times, Serif"><b>Expenses</b></font>. The Company covenants and agrees with each Agent that the Company shall pay or cause to be paid the following: (i)&#160;the fees, disbursements and expenses of the Company&#8217;s counsel and accountants in connection with
    the preparation, printing and filing of the Registration Statement, the Prospectus and any Issuance Supplements and all other amendments and supplements thereto and the mailing and delivery of copies thereof to the Agents and the Principal Market;
    (ii)&#160;the cost (other than the Agent Expenses described below) of printing, preparing or reproducing this Agreement and any other documents in connection with the offering, purchase, sale and delivery of the Common Shares; (iii)&#160;all filing fees and
    expenses (other than the Agent Expenses described below) in connection with the qualification of the Common Shares for offering and sale under state securities laws as provided in Section&#160;4.02 hereof; (iv)&#160;the cost of preparing the Common Shares;
    (v)&#160;the fees and expenses of any transfer agent of the Company; (vi)&#160;the cost of providing any CUSIP or other identification numbers for the Common Shares; (vii)&#160;the fees and expenses incurred in connection with the listing or qualification of the
    Common Shares on the Principal Market and any filing fees incident to any required review by the Financial Industry Regulatory Authority of the terms of the sale of the Common Shares in connection with this Agreement and any Terms Agreement and the
    Registration Statement (including the reasonable fees, disbursements and expenses of counsel for the Agents); and (viii)&#160;all other costs and expenses incident to the performance of the Company&#8217;s obligations hereunder that are not otherwise specifically
    provided for in this Section. In addition, if Common Shares having an aggregate gross sales price of at least $15.0 million have not been offered and sold under this Agreement by the 24-month anniversary of this Agreement (or such earlier date on which
    the Company terminates this Agreement pursuant to&#160;<u>Section 7.03</u>), the Company shall reimburse the Agents for the reasonable documented out-of-pocket expenses of the Agents, including the reasonable fees, disbursements and expenses of counsel for
    the Agents (including in connection with the qualification of the Common Shares for offering and sale under state securities laws as provided in Section&#160;4.02 hereof and in connection with preparing any blue sky survey), in connection with this
    Agreement and any Terms Agreement and the Registration Statement and any Issuances hereunder and ongoing services in connection with the transactions contemplated hereunder (collectively, the &#8220;<b>Agent Expenses</b>&#8221;);&#160;<i>provided</i>,&#160;<i>however</i>,
    that the Company shall not be required to reimburse the Agents pursuant to this&#160;<u>Section 9.02</u>&#160;for Agent Expenses in excess of $75,000 in the aggregate. The Expenses shall be divided among the Agents in amounts proportionate to the aggregate
    offering amount sold by each Agent under this Agreement and any Terms Agreement, after taking into account the amount of Expenses actually paid by each Agent.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 33 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.03<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Notices</b></font>. Except as expressly set forth herein, all notices, demands, requests, consents, approvals or other communications required or permitted to be given hereunder or that are given with respect to this Agreement and
    any Terms Agreement shall be in writing and shall be deemed to have been duly given if mailed or transmitted by any standard form of telecommunication, addressed as set forth below, or to such other address as such party shall have specified most
    recently by written notice: (i)&#160;if to the Company to: 400 W. Parkway Place, Suite&#160;100, Ridgeland, MS 39157, Attention: Brent W. Wood, Facsimile No.: (601) 352-1441, with a copy (which shall not constitute notice) to Goodwin Procter LLP, 100 Northern
    Avenue, Boston, MA 02210, Attention: Ettore Santucci; and (ii)&#160;if to each Agent, to: Robert W. Baird &amp; Co. Incorporated, 777 E. Wisconsin Avenue, Milwaukee, Wisconsin 53202, Attention: Syndicate Department, Facsimile No.: (414) 298-7474), with a
    copy to the Legal Department; BNY Mellon Capital Markets, LLC, 240 Greenwich Street, 3rd Floor New York, NY 10286; BofA Securities, Inc., One Bryant Park, 25<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, New
    York, NY 10036, Attention: Hicham Hamdouch, with a copy to the Legal Department, Facsimile No: (646) 855-5390; BTIG, LLC, 65 East 55th Street, New York, NY 10022; Jefferies LLC, 520 Madison Avenue, New York, NY 10022, Attention: General Counsel;
    Raymond James &amp; Associates, Inc., 880 Carillon Parkway, St. Petersburg, FL 33716, Attention: Syndicate Department; Regions Securities LLC, 615 South College Street. Suite 600, Charlotte, NC 28202, Attention: Regions ECM Desk, Facsimile No.: (704)
    632-3765; Samuel A. Ramirez &amp; Company, Inc., 61 Broadway, 29th Floor, New York, NY 10006, Attention: Lawrence F. Goldman, Facsimile No.: (212) 248-3856; TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, NY 10017, Attention: Equity Capital
    Markets; and Wells Fargo Securities, LLC, 500 West 33rd Street, New York, NY 10001, Attention: Equity Syndicate Department and the Special Equities Desk, Facsimile No.: (212) 214-5918. Except as set forth in Sections&#160;2.03, 4.03 and 5.02, notice shall
    be deemed given on the date of service or transmission if personally served or transmitted by any standard form of telecommunication. Notice otherwise sent as provided herein shall be deemed given on the third business day following the date mailed or
    on the next business day following delivery of such notice to a reputable air courier service for next day delivery.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 34 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.04<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Entire Agreement</b></font>. This Agreement constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, representations,
    understandings, negotiations and discussions between the parties, whether oral or written, with respect to the subject matter hereof.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.05<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Amendment and Waiver</b></font>. This Agreement may not be amended, modified, supplemented, restated or waived except by a writing executed by the party against which such amendment, modification, supplement, restatement or waiver is
    sought to be enforced. Waivers may be made in advance or after the right waived has arisen or the breach or default waived has occurred. Any waiver may be conditional. No waiver of any breach of any agreement or provision herein contained shall be
    deemed a waiver of any preceding or succeeding breach thereof nor of any other agreement or provision herein contained. No waiver or extension of time for performance of any obligations or acts shall be deemed a waiver or extension of the time for
    performance of any other obligations or acts.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.06<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>No Assignment; No Third Party Beneficiaries</b></font>. This Agreement and any Terms Agreement and the rights, duties and obligations hereunder may not be assigned or delegated by the Company or an Agent. Any purported assignment or
    delegation of rights, duties or obligations hereunder shall be void and of no effect. This Agreement and any Terms Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties hereto and their
    respective successors and, to the extent provided in Article&#160;VI, the controlling persons, officers, directors, employees and agents referred to in Article&#160;VI. This Agreement and any Terms Agreement are not intended to confer any rights or benefits on
    any Persons other than as set forth in Article&#160;VI or elsewhere in this Agreement and any Terms Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.07<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Severability</b></font>. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or any Terms Agreement
    or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or
    unenforceable provision as may be possible and be valid and enforceable.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.08<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Further Assurances</b></font>. Each party hereto, upon the request of any other party hereto, shall do all such further acts and execute, acknowledge and deliver all such further instruments and documents as may be necessary
    or desirable to carry out the transactions contemplated by this Agreement and any Terms Agreement.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 35 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.09<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Titles and Headings</b></font>. Titles, captions and headings of the sections of this Agreement and any Terms Agreement are for convenience of reference only and shall not affect the construction of any provision of this Agreement or
    of any Terms Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.10<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Governing Law; Jurisdiction</b></font>. THIS AGREEMENT AND ANY TERMS AGREEMENT SHALL BE GOVERNED BY, INTERPRETED UNDER AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND TO
    BE PERFORMED WITHIN THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO PRINCIPLES OF CONFLICTS OF LAWS THEREOF. Any action, suit or proceeding to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or any
    Terms Agreement or the transactions contemplated hereby shall be brought in any federal court located in the Southern District of the State of New York or any New York state court located in the Borough of Manhattan, and the Company agrees to the
    exclusive jurisdiction of such courts (and of the appropriate appellate courts therefrom) and each party hereto waives (to the full extent permitted by law) any objection it may have to the laying of venue of any such suit, action or proceeding in any
    such court or that any such suit, action or proceeding has been brought in an inconvenient forum.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.11<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Waiver of Jury Trial</b></font>. The Company and each Agent hereby irrevocably waive any right such party may have to a trial by jury in respect of any claim based upon or arising out of this Agreement and any Terms Agreement,
    or any transaction contemplated hereby.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.12<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Counterparts</b></font>. This Agreement and any Terms Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which taken together shall constitute one and the same instrument. In
    the event that any signature is delivered by facsimile transmission or by an email which contains a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party
    executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.13<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Adjustments for Stock Splits, etc</b></font><b>.</b> The parties hereto acknowledge and agree that share related numbers contained in this Agreement (including the minimum Floor Price) shall be equitably adjusted to reflect stock
    splits, stock dividends, reverse stock splits, combinations and similar events.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.14<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>No Fiduciary Duty</b></font>. The Company acknowledges and agrees that each Agent is acting solely in the capacity of an arm&#8217;s length contractual counterparty to the Company with respect to the offering of Common Shares
    contemplated hereby (including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person and will not claim that such Agent is acting in such capacity in
    connection with the offering of the Common Shares contemplated hereby. Additionally, each Agent is not advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction with respect to the
    offering of Common Shares contemplated hereby. The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and no
    Agent shall have any responsibility or liability to the Company with respect thereto. Any review by the Agents of the Company, the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit
    of the Agents and shall not be on behalf of the Company.</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 36 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.15<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: Times New Roman, Times, Serif"><b>Recognition of the U.S. Special Resolution Regimes</b></font>.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In the event that any Agent is a Covered Entity and
    becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Agent of this Agreement or any Terms Agreement, and any interest and obligation in or under this Agreement or any Terms Agreement, will be effective to the
    same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement or any Terms Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In the event that such Agent is a Covered Entity or
    a BHC Act Affiliate of any Agent becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement and any Terms Agreement that may be exercised against such Agent are permitted to be exercised to no greater
    extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement and any Terms Agreement were governed by the laws of the United States or a state of the United States.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For purposes of this Section&#160;9.15:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8220;<b>BHC Act Affiliate</b>&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with, 12&#160;U.S.C. &#167;&#160;1841(k).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8220;<b>Covered Entity</b>&#8221; shall mean any of the following: (i)&#160;a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12
    C.F.R. &#167;&#160;252.82(b); (ii)&#160;a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;&#160;47.3(b); or (iii)&#160;a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;&#160;382.2(b).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8220;<b>Default Right</b>&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167;&#160;252.81, 47.2 or 382.1, as
    applicable.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8220;<b>U.S. Special Resolution Regime</b>&#8221; means each of (i)&#160;the Federal Deposit Insurance Act and the regulations promulgated thereunder and
    (ii)&#160;Title&#160;II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<i>Signature Page to Follow</i>]</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">- 37 -</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin: 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
      executed by the undersigned, thereunto duly authorized, as of the date first set forth above.</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">EASTGROUP PROPERTIES, INC.</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="width: 50%">&#160;</td>
        <td style="text-align: left; width: 3%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="text-align: left; width: 47%; border-bottom: Black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brent W. Wood</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Brent W. Wood</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Executive Vice President, Chief <font style="font: 10pt Times New Roman, Times, Serif">Financial Officer and Treasurer</font></font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">ROBERT W. BAIRD &amp; CO. INCORPORATED</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="text-align: left; border-bottom: Black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Christopher Walter</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Christopher Walter</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">BNY MELLON CAPITAL MARKETS, LLC</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="text-align: left; border-bottom: Black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Dan Klinger</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Dan Klinger</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: MD</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">BOFA SECURITIES, INC.</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="text-align: left; border-bottom: Black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Hicham Hamdouch</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Hicham Hamdouch</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">BTIG, LLC</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="text-align: left; border-bottom: Black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Steve Ortiz</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Steve Ortiz</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</font></td>
      </tr>

  </table>
  <p style="margin: 0">&#160;</p>
  <p style="margin-top: 0; text-align: center; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<i>Signature page to Sales Agency Financing Agreement</i>]</font></p>
  <p style="margin: 0pt 0">&#160;</p>
  <p style="margin: 0"></p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin: 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">JEFFERIES LLC</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="width: 50%">&#160;</td>
        <td style="text-align: left; width: 3%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="text-align: left; border-bottom: Black 1pt solid; width: 47%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ William S Cowan, Jr</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: William S Cowan, Jr</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">RAYMOND JAMES &amp; ASSOCIATES, INC.</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="text-align: left; border-bottom: Black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brad Butcher</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Brad Butcher</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Co-Head of Real Estate</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">REGIONS SECURITIES LLC</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="text-align: left; border-bottom: Black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Edward L. Armstrong</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Edward L. Armstrong</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director -- ECM</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">SAMUEL A. RAMIREZ &amp; COMPANY, INC.</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="text-align: left; border-bottom: Black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Richard Viton</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Richard Viton</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">TD SECURITIES (USA) LLC</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="text-align: left; border-bottom: Black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Dawn Crandlemire</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Dawn Crandlemire</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Director</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">WELLS FARGO SECURITIES, LLC</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="text-align: left; border-bottom: Black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Elizabeth Alvarez</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Elizabeth Alvarez</font></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</font></td>
      </tr>

  </table>
  <p style="margin-top: 0; margin-bottom: 0">&#160;</p>
  <p style="margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">[<i>Signature page to Sales Agency Financing Agreement</i>]</font></p>
  <p style="margin-top: 0; margin-bottom: 0">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <!--PROfilePageNumberReset%Num%1%Exhibit A-%%-->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT A</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM OF ISSUANCE NOTICE </b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: [&#9679;]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]<br>
      Attn: [&#9679;]<br>
      Email: [&#9679;]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference is made to the Sales Agency Financing Agreement between EastGroup Properties, Inc.
      (the &#8220;<b>Company</b>&#8221;), [&#9679;] (the &#8220;<b>Agent</b>&#8221;) and the other parties thereto, dated as of December 16, 2022 (the &#8220;<b>Agreement</b>&#8221;). The Company confirms that all conditions to the delivery of this Issuance Notice are satisfied as of the date
      hereof.</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company represents and warrants that each representation, warranty, covenant and other
      agreement of the Company contained in the Agreement is true and correct on the date hereof, and that the Prospectus and the General Disclosure Package, including the documents incorporated by reference therein, as of the date hereof, do not contain
      an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective Date of Delivery of Issuance Notice (determined pursuant to Section&#160;2.03(b)):</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Days in Selling Period: [&#9679;]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Date of Selling Period: [&#9679;]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Last Date of Selling Period: [&#9679;]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Settlement Date(s): [&#9679;]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance Amount: [&#9679;]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling Commission: [&#9679;]%</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Floor Price Limitation (adjustable by Company during the Selling Period, and in no event
      less than $1.00 without the prior written consent of the Agent, which consent may be withheld in Agent&#8217;s sole discretion): $&#160;[&#9679;] per share</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comments: [&#9679;]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">EASTGROUP PROPERTIES, INC.</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="width: 50%">&#160;</td>
        <td style="text-align: left; width: 3%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="text-align: left; width: 47%; border-bottom: Black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;&#160;</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</font></td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;">Exhibit A-1</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <!--PROfilePageNumberReset%Num%1%Exhibit A-1-%%-->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT A-1</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM OF TERMS AGREEMENT</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: &#160;[&#9679;]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn: &#160;[&#9679;]<br>
      Email:&#160;[&#9679;]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear Recipients:</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EastGroup Properties, Inc., a Maryland corporation (the &#8220;<b>Company</b>&#8221;),

      proposes, subject to the terms and conditions stated herein and in the Sales Agency Financing Agreement (the &#8220;<b>Agreement</b>&#8221;), dated as of December 16, 2022, between the Company and Robert W. Baird &amp; Co. Incorporated, BNY Mellon Capital
      Markets, LLC, BofA Securities, Inc., BTIG, LLC, Jefferies LLC, Raymond James &amp; Associates, Inc., Regions Securities LLC, Samuel A. Ramirez &amp; Company, Inc., TD Securities (USA) LLC, and Wells Fargo Securities, LLC, to issue and sell to [each
      of] [&#9679;] [and [&#9679;]] as principal for resale ([collectively,] the &#8220;<b>Agent[s]</b>&#8221;) the securities specified in the Schedule hereto (the &#8220;<b>Purchased Shares</b>&#8221;). Unless otherwise defined below, terms defined in the Agreement shall have the same
      meanings when used herein.</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.75pt 0pt 0; text-align: justify; text-indent: 40.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of the provisions of the Agreement not specifically related to the
      solicitation by the Agent[s], [each] as agent of the Company, of offers to purchase securities is incorporated herein by reference in its entirety, and shall be deemed to be part of this Terms Agreement to the same extent as if such provisions had
      been set forth in full herein. Each of the representations, warranties and agreements set forth therein shall be deemed to have been made as of the date of this Terms Agreement and the Settlement Date set forth in the Schedule hereto.</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An amendment to the Registration Statement or a supplement to the
      Prospectus, as the case may be, relating to the Purchased Shares, in the form heretofore delivered to the Agent[s], is now proposed to be filed with the Securities and Exchange Commission.</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to the terms and conditions set forth herein and in the
      Agreement which are incorporated herein by reference, the Company agrees to issue and sell to the Agent[s], and the latter agrees to purchase from the Company, the Purchased Shares at the time and place and at the purchase price set forth in the
      Schedule hereto.</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding any provision of the Agreement or this Terms Agreement
      to the contrary, the Company consents to the Agent[s] trading in the Common Stock for Agent[s]&#8217;s own account and for the account of its clients at the same time as sales of the Purchased Shares occur pursuant to this Terms Agreement.</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.75pt 0pt 5pt; text-align: justify; text-indent: 35.95pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<i>Signature Page to Follow</i>]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;">Exhibit A-1-1</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 128.15pt 0pt 125.2pt; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 128.15pt 0pt 125.2pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Schedule to Terms Agreement</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 128.15pt 0pt 125.2pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Purchased Shares:</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock, par value $0.0001 per share</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Shares of Purchased Shares:</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] shares</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Price to Public:</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$[&#9679;] per share</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase Price Payable by the Agent[s]:</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$[&#9679;] per share</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method of and Specified Funds for Payment of Purchase Price:</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[By wire transfer to a bank account specified by the Company in same day
      funds.]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method of Delivery:</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To the Agent&#8217;s account, or the account of the Agent&#8217;s designee, at The Depository
      Trust Company via DWAC in return for payment of the purchase price.]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Settlement Date:</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 20[&#9679;]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing Location:</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 31.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documents to be Delivered:</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.8pt 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following documents referred to in the Agreement shall be delivered on the
      Principal Settlement Date as a condition to the closing for the Purchased Shares (which documents shall be dated on or as of the Principal Settlement Date and shall be appropriately updated to cover any preliminary prospectus, permitted Free Writing
      Prospectuses and any amendments or supplements to the Registration Statement, any preliminary Prospectus, the Prospectus, any permitted Free Writing Prospectuses and any documents incorporated by reference therein):</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.8pt 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Officer&#8217;s Certificate referred to in Sections 4.09 and 5.01;</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top">
        <td style="width: 0.25in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</font></td>
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the opinions and negative assurance letters referred to in Sections 4.07 and 5.01;</font></td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.95pt 0pt 5pt; text-align: justify; text-indent: 0in"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the comfort letter referred to in Section 4.08;</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top">
        <td style="width: 0.25in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</font></td>
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if reasonably requested by the Agent[s], the Chief Financial Officer&#8217;s certificate referred to in</font></td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.05pt 0pt 5pt; text-align: justify; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.05pt 0pt 5pt; text-align: justify; text-indent: 0in"></p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;">Exhibit A-1-2</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.05pt 0pt 5pt; text-align: justify; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><font style="font: 10pt Times New Roman, Times, Serif">Sections 4.09 and 5.01;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.05pt 0pt 5pt; text-align: justify; text-indent: 0in"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and such other documents as the Agent[s] shall reasonably request.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[</b>Lockup:<b>]</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[</b>&#9679;<b>]</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time of sale: <b>[</b>&#9679;<b>] [</b>a.m./p.m.<b>]</b> (New York City time) on <b>[</b>&#9679;<b>]</b>,
      <b>[</b>&#9679;<b>]</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time of sale information:</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares of Purchased Shares set forth above</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The initial price to public set forth above</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</font></td>
        <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[Other]</b></font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">Exhibit A-1-3</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT&#160;B-1</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM OF OPINION AND NEGATIVE ASSURANCE LETTER OF GOODWIN PROCTER LLP, COUNSEL FOR THE
        COMPANY</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">Exh. B-1-1</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT&#160;B-2</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM OF TAX OPINION OF GOODWIN PROCTER LLP, TAX COUNSEL FOR&#160;THE&#160;COMPANY</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal">Exh. B-2-1</font></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE 1</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTICES</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sch. 1-1</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 0; margin-bottom: 0">
    <div style="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br>
    </font></p>
  <p style="margin: 0"></p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ny20006293x2_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right;">
      <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><font style="font-weight: bold;">Exhibit 5.1</font><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">December 16, 2022</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">EastGroup Properties, Inc.</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">400 W. Parkway Place, Suite 100</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ridgeland, Mississippi 39157</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Re:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>Securities Registered
          under Registration Statement on Form S-3</u></font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">We have acted as counsel to you in connection with your filing of a Registration Statement on Form S-3 (File No. 333-268821) (as amended
      or supplemented, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Registration Statement</font>&#8221;) filed on December 16, 2022 with the Securities and Exchange Commission (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Commission</font>&#8221;) pursuant to the Securities Act of 1933, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Securities
        Act</font>&#8221;) relating to the registration of the offering by <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">EastGroup Properties, Inc., a Maryland corporation (the &#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Company</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8221;),</font> of any combination of securities of the types specified therein.&#160; <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">The Registration Statement became effective upon filing with the Commission on December 16, 2022.</font>&#160; Reference is made to our opinion letter dated <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">December 16, 2022 </font>and included as Exhibit 5.1 to the Registration Statement.&#160; We are delivering this supplemental opinion letter in connection with the prospectus supplement (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Prospectus Supplement</font>&#8221;) filed on <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">December 16, 2022 </font>by the Company with the
      Commission pursuant to Rule 424 under the Securities Act.&#160; The Prospectus Supplement relates to the offering by the Company of up $750,000,000 in shares (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Shares</font>&#8221;) of the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Common Stock</font>&#8221;), covered by the Registration Statement.
      The Shares are being offered and sold pursuant to<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> the Sales Agency Financing Agreement, dated December 16, 2022 (the &#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Sales Agency Financing Agreement</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8221;) by and between the Company and </font>Robert W. Baird &amp; Co.
      Incorporated, BNY Mellon Capital Markets, LLC, BofA Securities, Inc., BTIG, LLC, Jefferies LLC, Raymond James &amp; Associates, Inc., Regions Securities LLC, Samuel A. Ramirez &amp; Company, Inc., TD Securities (USA) LLC and Wells Fargo Securities,
      LLC<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, as sales agents.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">We have reviewed such documents and made such examination of law as we have deemed appropriate to give the opinion set forth below.&#160; We
      have relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinion set forth below, on certificates of officers of the Company.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">For purposes of the opinion set forth below, we have assumed that the Shares are issued for a price per share equal to or greater than
      the minimum price authorized by the Company&#8217;s board of directors prior to the date hereof (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Minimum Price</font>&#8221;) and that no event occurs that
      causes the number of authorized shares of Common Stock available for issuance by the Company to be less than the number of then unissued Shares that may be issued for the Minimum Price.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The opinion set forth below is limited to the Maryland General Corporation Law.</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">EastGroup Properties, Inc.</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">December 16, 2022</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Page 2</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Based on the foregoing, we are of the opinion that the Shares have been duly authorized and, when issued, delivered and paid for in
      accordance with the <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Sales Agency Financing Agreement</font> and in exchange for a price per share equal to or greater than the Minimum Price, will be validly issued, fully
      paid and nonassessable.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">This opinion is being furnished to you for submission to the Commission as an exhibit to the Company&#8217;s Current Report on Form 8-K
      relating to the Shares (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Current Report</font>&#8221;), which is incorporated by reference in the Registration Statement. We hereby consent to the filing of
      this opinion letter as an exhibit to the Current Report and its incorporation by reference and the reference to our firm in that report.&#160; In giving our consent, we do not admit that we are in the category of persons whose consent is required under
      Section 7 of the Securities Act or the rules and regulations thereunder.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zdc3bb620a8f34cd5907e31cb6b227506" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Very truly yours,</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">/s/ GOODWIN PROCTER LLP</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">GOODWIN PROCTER LLP</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>egp-20221216.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<xs:schema targetNamespace="http://eastgroup.net/20221216" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:egp="http://eastgroup.net/20221216" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="egp-20221216_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="egp-20221216_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://eastgroup.net/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>egp-20221216_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>egp-20221216_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://eastgroup.net/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="egp-20221216.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://eastgroup.net/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140145121794736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 16, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 16,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-07094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EASTGROUP PROPERTIES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000049600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-2711135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">400 W. Parkway Place<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Ridgeland<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">39157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">354-3555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EGP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>ny20006293x2_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="egp-20221216.xsd" xlink:type="simple"/>
    <context id="c20221216to20221216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049600</identifier>
        </entity>
        <period>
            <startDate>2022-12-16</startDate>
            <endDate>2022-12-16</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20221216to20221216"
      id="Fact_0cc1d4f2056c4beda6a56cfbcfb41bb2">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20221216to20221216"
      id="Fact_b9cae21ff0ec47849ddf1bd1152b823a">0000049600</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20221216to20221216"
      id="Fact_fbfc371cef814cf78299ddec017ffde9">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20221216to20221216"
      id="Fact_cfd2bb6e082141788b95e6905a87f9fa">2022-12-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20221216to20221216"
      id="Fact_1f9d7d7f39f14d12bf0a86b56a1d4400">EASTGROUP PROPERTIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20221216to20221216"
      id="Fact_13f62b4dcb3d4f73969514baf712ee41">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20221216to20221216"
      id="Fact_c2d23bb3f46149749a2ce9f2e48ff05c">1-07094</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20221216to20221216"
      id="Fact_3d0069952e1e49a7b18c48f9f53f6c97">13-2711135</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20221216to20221216"
      id="Fact_e10f3f5e48c0454fba15dfd44ed54a1a">400 W. Parkway Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20221216to20221216"
      id="Fact_f5b0d41141f241d7b03a686d32f0dae1">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20221216to20221216"
      id="Fact_1339b8a60e314a9aa92836ce2d6ec046">Ridgeland</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20221216to20221216"
      id="Fact_19961e96bd6343868853d2a4b624c1ec">MS</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20221216to20221216"
      id="Fact_661592a807e84ce99b1f7a09b07d488c">39157</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20221216to20221216"
      id="Fact_9455b81cd97648da936a385c4843641c">601</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20221216to20221216"
      id="Fact_d3557124fd34412bb44e3e1744b65417">354-3555</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20221216to20221216"
      id="Fact_1f3a4beaf97543a0a960838b60e1f6c1">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20221216to20221216"
      id="Fact_076d3ab4c7c94cf289d2c1d319c41063">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20221216to20221216"
      id="Fact_9ac2b1d6204f46f2829217a5335e57da">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20221216to20221216"
      id="Fact_0c3904ad4b69450ebf2f13d659c12a32">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20221216to20221216"
      id="Fact_12ec10cd27b149039eb5104a1d747a33">Common stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20221216to20221216"
      id="Fact_e1dc135bfe6945acbbbdbbc9439957e3">EGP</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20221216to20221216"
      id="Fact_7a16d78b2a374550861cfbe557abaa55">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20221216to20221216"
      id="Fact_b846ca6e0dfa44dc91a1c1ac544a328a">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MP %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ YH6059>*NQS     $P(
M  L   !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2
M!8I%G;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4
M+!XUA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(
M2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/I
MKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #FA9!5'#AE
MZC\!   \ @  #P   'AL+W=O<FMB;V]K+GAM;(U1RV["0 S\E=5^0!-0BU1$
MN)0^D*H6E8K[DG6(Q3XBKP,M7U\G452D7GKR>FR-9V87YTC'?8Q']>5=2(6N
MF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,9
M2L88!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3 QFU+
MBLX5>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=R_$)
M'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D&IND
M53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&L&]R
M( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ YH60
M520>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61
M/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?
M:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-D
MGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R
M&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    (
M .:%D%5ED'F2&0$  ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM;*V334[#
M,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7
MK-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ
M*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@
M9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WC
MEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2F
MKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_F
MB^$_7G\!4$L! A0#%     @ YH6050=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #FA9!5(C'Z$.\
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M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .:%D%67BKL<P    !,"   +
M      "  8P/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( .:%D%4<.&7J/P$
M #P"   /              "  740  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " #FA9!5)!Z;HJT   #X 0  &@              @ 'A$0  >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #FA9!599!YDAD!  #/
M P  $P              @ '&$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    "0 ) #X"   0%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ny20006293x2_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eastgroup.net/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ny20006293x2_8k.htm">ny20006293x2_8k.htm</File>
    <File>egp-20221216.xsd</File>
    <File>egp-20221216_lab.xml</File>
    <File>egp-20221216_pre.xml</File>
    <File>ny20006293x2_ex1-1.htm</File>
    <File>ny20006293x2_ex5-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ny20006293x2_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ny20006293x2_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "egp-20221216_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "egp-20221216_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "egp-20221216.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "egp",
   "nsuri": "http://eastgroup.net/20221216",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20006293x2_8k.htm",
      "contextRef": "c20221216to20221216",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://eastgroup.net/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20006293x2_8k.htm",
      "contextRef": "c20221216to20221216",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eastgroup.net/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-22-045890-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-045890-xbrl.zip
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M0!%BW 04!+CR9BH7G?XJ@U(:?GM05CZA:8;B?\C&VCYP 4VJ:T#@VKMH7>(
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M?>M[25$D,[#@]([D211RXD5@I,WU(DD/B+E\<2K0/TF[OUM8>67*]UAYQT6
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M-R>^K"7/&!SJ=BKDG>FE0F^8$Q83P-IX5V-")EER6TP1=:=8_&4YX2((8]6
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MK^]'EM8#2\3_/U4!)27+>A=DR8P4X4S@+O)O0-;5VJSHPT[]F=2J:D9#88[
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MKZDO?X ((E>D^.^],=BCD_F/RUY.UQ9@ X@W+-^S[G\#G:(O&P>L"3C?P0.
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MR"VBX*=:95;+,H=#W>9QU\GANMJ(ZI'0(B0H0<YWH1_-T )ODPB@0(LPMJ;
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MHJK6@1)L</K6KC\JQY6,[)<[FYL;AG6.H7;P/W;.$.()Q/]*<PSZ=4<,*Y2
M$M%11'JEU/3*[?"L @N^J@F?94B8($P54F&9<8$O]^4([N+X$SYH*(3':-UM
M[IQ1H<3ZU/!_AFSB$^M?N*B!X<GEY2^]TZ-^T#L]IB;?P=D[< ,_?CP[#2ZO
MSHY^?IQO?/RVAH?/I*VARUB@O0R?WH[Y*F\^P/?N1+N//8W^9%ZNP)U@-!YO
M4NTRZSIYZ%G7VF37. *D%QE>+*Q(F%S!$(37T)U:1SE/IM2+:48G+ +T@)UB
MUWV&$QEH!BUP4(OZ%K=]+/N@;@&;U%"GU._69)*X]UI[DZ_:>&OC; L]N+S3
M55HFDU7H&)K$&13CT?!J@Z^;& +\M[6UFH[_6463PF7-9@G4J+.SQCL2-U5F
MR;#W@]IJ SG'UQES=W,82<R<E<IVG6[EXK0+0J_)$(*/<GJCZ61YI&;*2!87
MPSP9Q#0>:I:*!@"V\^:/+ZIB1MD [+$*]U''0+< S/G@]@)^78,M']3*HG:7
MP&Y:E4N%NCH7I>'?P'LX6FP,1>U)5YA^;9:"Q2=8$9%PH_A2FQ)*,[6EQ"R8
M&,\ZS%G:D$9BR\34]O3]H&][@)*()-KHTK*-$_AR.D!K/=O2+,!:.+&H:>7!
MK$I1:SV6E((:EW#H\GA3PK7JTV@4BY1;0K V)0WJAC08JQP*J,&_G(Z/S8:I
MI"+K'>M"(5#)L5@WXU;<;AQ8-UBM4=TLFM/RJ8D')L04_4J4BP7@R!Q5/JV9
M^L>);H03+,4V@68_M9G+&D9+TOW@)%5U;L03NFPR3,MG-7[K>=':&7%I,+I^
ME(':RZ2#HT-.U$I@Z!U-YFAKCU0+PR!.G4(&..Q-EB?O%SA*8@21E+'M\1[L
M(  BM/7?"SV67=Z0+C&(806!124$($%O[T !"SNTY3@B3SC=@J<=AU,8WD6&
M/)#.'<PM:8\K>+?M8D9[&F1%W1(B%U ! [S-)M2T@1K(TB;$CK)T*QSK>8Q)
M0^XF;_HGKD"'0G*2TG?G=8.8.UC#?.;L'$>%)\QED-)=[CIK/G7X*<WN0/%?
M<YI3]"(.0_H3[R2V742.=@(. K5.!)LEM[06C>4-8P=]7(RK"<VB!.!K6RR$
MY^L+')'3,^!#JISTFX'0X^EDZGCK6UW*CKT.P,D8U=@HBPM#WMG8Y6.YD<\@
MOE\7!04IQE$R0<+&P;RV+![S*.M:0@W%)%T_$B-GD*A+:@I3Q0J<A.=*EX4P
MJW+82D7=+L-$AU4-P2""+US8>P2S>[-2MZ$],G&I\ $\)/E90)(C;%7ZCEJ/
MZH;?-M>^<J[]U3;7_B?,M;/?/7AB?C<6/!,Z$(_D,],K&DTV/'?,>6-U!Z\5
M.8S)-HF9PYA\O9T#T5,)P29OX<R=H.5Z#<8RN2(>'<1.,A:?&%G#QFT@1FFV
MI(H%;1CFFX'C>>=07H:>T00+?!IHR9V7<@DA-.<>(!+_#H8GG=@SJK<3OIA)
M=.<G8^$@D4,Z*L6H1/]!0[/*1&/(S=2!]0EN#KH);JB>3+K%\T%"AKNQZKHP
MI6B!V\NQS95MMQ[)*.%_/L%+W;^DS+J99VDR]$E_X&B+R[LL_[2/_LT-!?3K
M\0<]J^NNNYY(+ 8K0*;IA ,U(>'C!+.=BG>J'3 UJ[#6L;R1C)]A5VN6%*KL
M5+P*[^FX/(G;&M=D(H=XG);&GE1?D2[OY+OVK2W'KJ*EY-KE(?T*[D^P:9%E
M9^% @+ET4,T-PTJG5U8#+IB#GAE8>(DZLTF;QUBM=+3C72 @^)CK!(D?1NB8
M#:K28QB'I[18O6'CM.;WNW?BA&);M9;;51YM/HHLXB)"9O1H_L<&7 \>-=PZ
M?'IJWZRZOM#NLK[_9=85H#39NSI%JHE4:D16EJ 7%B!7E#W?5O"%!;*$"YE"
M0Y]%N"MB*L\O;&D3?0K\XU!>PR<+!M1@199)@2JF&4PVG,1N.,]U.Y>%_(3:
MR,*1;I(8G5^J+8 !",E#Z/SQG2%T,G_$X=A[?DTH<!(7R<A1QY=QBMT ZG_T
M6*!"-SZ <5!CH_,N7YTJ6:*0Z.&X?D-K "X*4K*BFX'IU5HF4@!85UZ--[B)
MHJN]W0NZU'!_;>TA2);CG(V(R!!'TCD6\:KC;X\_PS6-X7!8?NS%=^E=S4?>
M9166CH _'J.OC9 ']RUK?VG8_"@Z&PRI]538@NQL$.=7%S=FY^3(W#LS1(>B
M<=0%"OHEWR#A5/-;$X\@D)?)GM2"T\-YO9ZY%B+UJ(HWX^!I9FX/'^\,>HB<
MK>F=AIQY;N*6K+38_6M+?]@=7 9.&\!&,_-=:VA9TQ7I\8+9)!K224.TKRG:
MXR8W8(O$\'AQ#X/:^]M+M-360@:(2>S&VP4.(P>-ZS0U"_] 5X\2]K3LLE?C
M>)'^\X7&WX\4?4E:Q<:^I*!M,C%QKFI0H/T'W]20.:G.*B=#/'?+:0LMIVU8
MMQHWAT-DEG$64T9@O[Y&]ME,,U(PF+K_1JX,6]8$'+B+N6J":%R*BP8SF*-K
MF^*<DGK.QLQ&J(\P+Z!6O/M!C[U#65RAQ+MU1@S"R9M-$KI=9Z'T3!B[W7I:
M5B:3#A>@SR=EE,995;C+4D;PHQ< KEGTRK4HYZKT/(Z"H4,S5;=>0)O NB51
M4$>&7H&A4<*-VK_4+(X"T:7L1W)H/YI%X"3!7T8<$;#C9=6]TY,Q\TCFK,0C
MS7LKH;A)#: 3DDO*7S82[JA9$IM)AT6232J6^*C"..4HFSG?]3:+<G(^C\GC
MSO*B]AF"X*=;F9?E7S%WI\:H0:SI*?-'/7A6U@]6$PA[IEW'+3K X]'$5\-W
M[)@00FB:1!&/3<0$-Z0J]!QLW4;= >!=;7ZEWR?;6M<ES.VX@G_";E9WW-"%
M4J;?R%/;=_-2<)8:Q;G?-F?>YC5 T(5F8T0GD-6#J08P:, *0-<A=HAS#)A_
MBE8^K,,(R7<*4\HK>0:P@NQ*Y[V@TX+J"?\?YDW@8\>U9?'&R8 \S [K\@^L
M*C2V_<.Y!20H;P -'V3IMI9$+0Y$=C@1S+;O\5"SXKJW99>Z%?#L?-Y%>8[Y
M0PT\U@:.&R'26%M]2_F*(<>=+?M,7JA/P4RYT,W&C*K!Z3,4N/)I2-2+-O6X
M04EK\^@<+S3/"KCVA_NT:<;+U76R.30(AFL\]X]X_NPF4X?I/_+&30^]S[(1
M'#:(C1GB.?;APWE(Q<[@!-12;N'B50H#%X(\2F6C^8]S:Q.'H&9+]$T[M#A]
MV6@$LBOXQ(I-SCY<T"_"9H;Y@][N'1B5;W%?989??;OHH\OH\Y=].-TIW_[U
MO^ZPWB$#/DR_Z^?SC^_Q8UK'J\5A,NC%LT%KFOMQB E7TAP:UWXN09"(Z2,\
MD;QAW7S;K>AFT5Q..^XKNZ1Y+.K,D.9/GPR_T+#, ,V87'BCQW9Z,%]:45L2
M5N1&97J"L/F!UDVWS3*NG&5\O<TR_@FSC$VO_^5C1YX?PO?_&",@*!EZ^9)B
MB]Y^@ND$VVMJ/SAK) (DMN_!MNH!_GH,?D$'0 _M5NN_9PXT-ZJR?KK BY_@
M9X7X"\'NF9]-7,4DP-NBG^A->!Q"3L:X=JK5ZY9;2I!5",T$G01@UV=]7ZV[
ML TSUWHBK]=.V+IV)I&?9B4^ ZT3 5;-UTQ"V_P4&!#YO"4F3GD?$)4&JEQ#
M?E&O0 ,G9LR"O @VI^25EZ'CV_@/#$A+_&XV 3%+<QW3X$Q$9ZU.B.!&W28<
M$NI&X+<+4(UC)X;?WF3 3XX[HB5/#KMWDM%)+4?\>><D%'+9!":HHQVS4;)M
M=1/-:1C,O:9U<XLUH_Q+D=&?.:M77P.4CBRR+.6T)$'V<&N%P30;@=)E!P]#
MCA;'5X<!TE?C<^E+2*(\GLU(+SQ9.-.Q$V-K/91Z:4W]RH*2_6"G4P.,]>BK
M0]K NMD]WRBVD%#M">)4X$+2Z/$T2HP?ZNCR&46@ZJ>1U,\&!VZ>0"(FS1,"
M?XPG\>P&41@V"@A.X6T&'T9OGF*"\=J@;>2U$EW. @H*T6;9#:W.(;5A=#%^
MF?P1#/9_5JB+_",B-64N#C9?=A0^;P+[QYP?^N6-W8[(H\9N[YP<.7F<.2E-
MA3*A7-M;D%I\BF=\;/W#E?W#[[;^X9_0/WRR<*1WDPSVN*'F)#7="L_P=;="
MYK!2D'2,\QP71^2HW#K3E-:+N'=JK<D(I=C4N(( )*VUTDLH06G-E1HVWJL0
M:]0I."_>)--B]/36J!XE[ZL$SYN4(Q"^(<S).+%J:_4Y'H34!HQ-:[[>&//L
M44EXWKGGT%)>,['5(I;[D$?YT8$6:Y<#(DDD-+>7/##T;'4$\MA9P"&AA@5!
M;&KI/'B0Z4I1V ?5DT2:OH 5GDI(BH9O 'SLX0^JN2G8#FU-'6=.3#DU_#C)
M$ ( K[P!6TE#PF$7@&F5$4HFB$"IM)^=S8>T*+4RO^X4Z?(X@;),_-1:[V?5
MG)?G)Y?*23ES T@"=XS4\V%[2BI]"@L*;U;A^*MLD]1)_/3426NUGSG?6+6<
MC#UKE5;*75+<,"*Q1G6P3D:_O03,BZ<E4LI'?O2\#7=G\LC8K#2C3)@M*7?+
M%9P/I&_"9=G!FF"_#K8WUISAM1(G\=^R8RJ=.4HX1)6,-XZR>EE@>R!B%[9*
MZ !T\"\5$386#I1&-45C8$+'RZ/QPY:U(M26ZMI&\42C -LK.U?&@U:!7IFK
M/3>RY26NCADD[-?Y'5T5V$/C%JX"IBU0$HB.;R1%18>:@30XD)=8KJV/B$5)
MJX!3ZXTO;Z?"Q"IM"K_=RBJ,R(J"Q8G?5MXAK-M[5 ?<QOR](:RP:R@->5*L
M,9L(=-4E=6AAX="C!:>G70&8< /5].@)N@9_ YL:S>_A[2(96R$I4/B=!U6N
M#]O6A)ARTM)D:]WH&ECM#1F9.G8NY)D3^B6B\C 8 F\VM\Z:@2 .WD_Y+AH#
M\XXWW@5#Z] S'M]8T>[(%RC)175-]5.9:@=HDK2A,^E0 SGSP"RA@V2QMB!#
M(KLP+:&-D)LQ%.L0Y81MJ)BT?2NBQS5?M,QU_O"U%D'>NLP'=J48WZEQ=+1$
MO3GIP#X2/B-*1J;4P)6089[PWLQXJ(YE11%I%'4H:FD<59.2UB]9SAC#BO."
MS6 R#(=RJQN)=XW#M+E4F]*P6\>$MPD!YS($>']H< 2X9$?=? '=)*AO."3N
M?X?&RYO >3:_'3_ ?5_W6QC)P4AID(-?%3,R99;M$T>UANUYGUHZ1TN,6"BI
M5"@:E<:,$MY*P>@B';R<16H]>UFAWE'U)-6T,9AD,\SC)F+@VS]WG8!=I'Z5
M0(WTR=$3]18YOX:"VQO$2 W%5DUCG[C+#.UD*NPD@WD8:1V5 3%%<@Z%3N4M
M4Z(8F---DP2*E8%VF &K=<30)N,2-.WQG-[+Z>0X-JE714^!NXOGY'$,AG1"
M4*\K[&=I/D1!__@0N>@OO\'V&.71':B9'EP)EV>C!,[6G>/?>D>[P>6\*.,I
M?;V>R%IE';%PC3:P+"[3"NF$+&&$T+GPS#1J)(1BBQ(JL]*WB1N<).(5,(9S
M2!ZQ.3W'\#(6^BAF]:;RYY^X:('-5</4<9UEQHXE42.0SDLJTJP;>!Z="@S-
MKM$<85I<JE^#,1P[+@$X6X>=*#<S0RZL3;&AWLI4I]'<(6==H5Z03\*BPZZO
M/?(/ZU55W'_(5),(]4B[Z=Q6-ZTNI2E+H )MSXO(I^QS7(,)5'"<=9(5,*_#
M291,$> XQ406(BD8;2@0@B7H=[@TFC D.<'C("[8%'**&R?Q-2SQ<2P&FH(9
M=^E(3+CZ!VVR/"%<);Z!&C>A7.L!+OHD:V348DY,Z2(B(/!D+28\#YJ=&/ B
MX_%R[:#A81$CP5BEF,VC>KEH0* -=SAL*=<WF0U56NM44GYHJS.@F<[0&O:Y
M#5M02P$.LCS/[KJB='1$<R/<24P91Y80WEF)P5Y?G)24QZ5)\3!D&!9T>"7?
MRJ^$\1;;E-[**;WOMRF]/V%*KVG O?IS&W"_<!G@.]1 OPF8VV\2:VRZ4V']
M<,^;5$)_>J 0' K4'>INT">CT&-@(UK7HLR3 8:LK TG]] M<D?C<H-+@K]U
MC-8#U+%9Y%&.:&"S!6FW*9#6YOI]_?77;^#_ST- E+5:Z#1+]\XK."&'P4F*
MIV:D+'YVV3;=75T<ZI6TA/6Z 'M1,U..U$Q\1O,J-\0&-?H%4[>D?9C0P.24
M=>(PB=HR$5ZO [ 9XULUZCRT*M,N&52.)5%B.P(LN;C0[S,%5BF(;,8B2ZS(
M-G<#?/<8"OQ!:O0_Q],9?059=8TLM;<+3KA@G!F;FDLJYF?=>JZZE^"PW%H'
M+PYVAKL[!]1[;.7<^([C/M,F,5EB"9(%$;I\U^BP)>(VXBZYS285>'&WT:1B
MVFU!L4Y@FY3!?QXHG)J_!<L0*5&G;6(3/C'N;K#>?<@;$BFRRKD[!$[\!K(M
MQI,,'N6\T;S,16_CJP@HHX0V#4!S+=/3$J],2AM/ _E/YF[^SSG!#$-786+T
MM:+\-M"Q$\<6_FJ368I*F[!OG?L6PAX;A35>W#^JT;5) %!M&CDZ3U"9/+6&
M&(LZ8ESTSR_ZE_W3J][5R=GI)37&^*UW<=$[O3KI7V)[C*N_];%%QGGO]/=-
MZX[AXG],VL<K7[99-(F&X+X,70P0JPJ;"_**-R-;LNXQV7A_,50#IC^ 'X9O
MA+T;80G[+ _)5L\/F'I^@X$S.KN#4T,TC6,6&SV@271*#,!;Z0;X>4=I,#1W
M4K 1CI0F&-;(;F/&6%M3WN1(1 !.XF)Q;_7=.K_M@%$"$P(;)&E]\"[&&N-K
MV;":2O7I,,MG6:YQ.S-BSG$E0H9 >3;]5L-QO>L'G:.@9= _/CTM]D>81"^?
M2=L9=WLT&(R\H!@M;1.+[FP!>7"(O'FR2QJX/WB(I2Q"\+U@,OY99:6M7FB0
MBEIK20V>8CX%W:W[J?_^/%3J4X<LTJ=UDY-:W.EZ?%(&TS4"$^/V"5.0AR@O
MRD9Q@,/3[Z3'!6Z+= URO8_4-#'H:1R7TC":F4IY6RHTHI)P!!R<?/WEWLM.
M(E<CD-;>TR:3K6Z7OL,C2U*EUTGX0HJ[D=2W$67M%%('"WB?!V^I+:7.=42M
MQV M([]40E%E0RAG&#+HR<J7RU>UK%HIL#QX2<\]^-;C]/#>2P N]4715S1<
MHS#08821X@BSM2FXT<&.UY8.CF!$AW+"H;!C0_07?(([K!,0JHZ)V-;AOX?T
MWV]#*IZF__*_7]%_7X?!MTAA$"%XC I$=^)=?WU\O_?S[C;JO'+4^8=MU/G/
M&W7VH.^@)GCGN^!)S5[AUJS*#$,[0S#_XLFX@R(.3P5?V>YX9N5IMA^\?/ER
M[_#U]]\?@L>_8Q*AUMY;0O+FVWX<YFH?#,-AIM)I:1 /,7UK:=\H+2WD>*S1
M';[OUX<[P]T%E-]=RA]#!*DVLL:LJT5;=:303!LC)X# (NE^NVEUI? EA?0U
MRV]=C>GSF6.,H)I<U_+4.N5=+Q?BV8[IWU$;>1F3("EX,==YW36Y!2UVK)5@
MT)? $^86Q,.FA2I1;41R14:,_XNTYYU7(<4',T%)%M*\&:2G=7<P'U$F9<6L
M.E%N:SB[]DRS?-WQGBZ-Z^,U>ZL3!1')U:?=7>,R(3*0C%%[OPOPBSC2,Z2F
ML@[/G5T!]22R=C-*'<5AKS%O\5!N9)6,:8*6C&?QJN)(H*3['?R[#T9MQOH=
MSQ,A)^V>9ZV7/$O NT+=4<]'K1M&KEVXFO5+,7YRW#&V1+JSI9B_W>,/*7K9
MZL_3FUQG?HE.-XO814JZ^4-U7U@REKEN,C>1 +8>QU)$<)M@),#9$XF#@O'Y
MPUKX32ON+5?'B"S7/6K"8DRWU<2N8X/:%?7AM^@E-G6U4P2]6&%;++R*U,I3
M9<X1'9,H%?W0$!RM!]K25A?BJN"2>?;O.B1KP*,@SWW4*!R>M@]:E6RSB=W3
M-"SE?)F$(IG$"S17';%>URUKSL1JDQ U_< VE=G\X/V@5U#NNXD'=\H</"/*
M5-J;)B>Y_LGN6OW;W0TXFQ0SM).V?BC0ZBS6<K&X_&1=U59ZFX4I$4E5BIT5
MD6:]T,$J5H]N-81S%5^B/I]@@N&/,OR3@M6;7Z)JHR"-<C!MO[D"8VTC)*/\
MU",*(EG5N:#C2'O?3W<YH>O"2E8H.QA(0@$D/L':PE1(R)./U(Q$?>,.J#:6
MSL=LV,)Q8KI_<D+Z$U<E'*LIUHCKKF:D+<@=2 *B7:&&=76J2_L]>"8Y++)C
M3F1@"\3S:/@)L]FK&WH[PVPR,;:1-:4=@[E3"-;!KK$_=\<(VC5VR*IEWLG+
MVQ7?; UF=@9GW6TKXW$/:K\LQN;84F3=48?(SK44<:&57Z7$0NP$.,;4G$N^
M BGJ*/,M#<@4@88_DR55<N-2_P:O9PC5ZN/8/>]8NO'(\IE@ 93AP4MR&"B3
MP&JFWJG)O\-FH5C9%I)6!'%,8LH$;,.:*X<U#UYLXYI_WKBF<TH]"P+5]L/C
M3?W@:!X6-=PB O5GH**H9SA#>$RK@[:(6(<78#)4 HR2$D6ZQ18BU+DZT@PU
M,O(22J4\6^T:#[O1S#\_.4VDY23WRHOAWVF;P\6G=-?I:L\NTW_&8; 7DG>M
M^^+??-$YU16>7?&H,@0)YKQRLHPDW>X/,7V;"+ BC ]?>(!U'UBU^ 5=9#TI
MN'W5$ZUV)#E%TKXEI)_L1569,6/D8&>,6:+]:]C?S/QV;H[K+W"-K^;B*P:G
M9S$X5UHBW#YDI^FU)<CSPFLZ:+-JBZ^P:.]E7K4OUWIG"?SJHF/%&J:A!UVV
MCV-GO5FV$,H6C)C=!!A]E<P(/%EJ)+Q60(NK%G:HZDTKX55'*R%39@-\M:%U
M.B."8C713L-;V_23M:5PR4Q:W'.#R%='4B<IN07?-ZFY)>+]_/N_J<W4?K)9
M'P6K1BR"@HF7P?!(1MAZ<!UI42RL;;S&X>GVS$*S)64-SQ]6]\H*6:J Z6=I
M9_('KOFUB+8IC.F3;+B(2Y=0"_VVN:%2(/B=_186GK#^".4*AG<YDD79/\)2
MI:HI$:=-<^F4*F"N,D5^(+=#=1UO[>9\XL\X\&+B)0C\S6.#MBKM-C#WHJB
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M"R<NJVQ$(1^T87RTP&T-H,MO%$SN0L E?TF2.]G^-[7<3XAQ>I@'[+T=N9G
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M.]!G,MM!D%R6XC&[E/6,$FF2%BLZ0";^P?S(@1QL)^_%%K5OW]<()WZ52*+
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M;3O17Y)UV&HW2,F\43H%.:_UH&B2CHY8&%0_EE'C$)(WZ"<+N*(D@E=!V"+
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M0\)\IU+OM'BL3#->8 MX0YA47Z.DB8I$V18DXRYQ6JP[*F(!M7@ENOP!L,/
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M((!\']7*9O46[A24EO;M;@6P<SLWA2>HGJG?J'LOG]+L;A*/KBE,S6WCVPC
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M=EWCSV0'?W0 ];)*G0YP:=?284G@VCZ-BE'T3UG,\G<STW95>O8I3QEZ$P3
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MB-RR"E!"E9IW/$)M="J5]ZP1UG\M=7HGA,U<C&!^4E+6'H!%%K%<)80!<.L
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M;!G$>N3GD"C!2]X?_=T'C3$S =1S^:2&UDO6;GE^"C+K)TP??1$F42@!"-.
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M1.TL34;I$=QA=&LF'49+6%$UX/I6<6KP/U1'_X1EX<F<QJ>I0SS3G*IQZ'I
M:C= W:3C!?WCO)C&\(__ U!+ P04    " #FA9!5<O'DG(0)  #V*0  %@
M &YY,C P,#8R.3-X,E]E>#4M,2YH=&WM6EESVS@2?M^J_0^]RFPFJ9)D';ZO
M*MN)4YEQ$I?DW=0^@B0H80T2' "TK/SZZ09!BCJ<<6)9DZE=50X2 M#WUXV&
MCL<VD:=__QO \9BSR#WALQ56\M/CK>)_/_B/5@NN1,A3PR.PZA#.M6*1%M&(
MPZ5(61H*)F&H9&Z%2DT3WJ=ANUCK/F]4F"<\M1!JSBSND1N1CNJ[7 \^Q4)R
MZ/7:W4Z[V][I['=J&URH;*K%:&RA>W"P RWH=7J]^OI6JQ!ER\MR'*AH"L$H
M5%+ID\:+V'T:8.Q4\I-&K%+;BEDBY/00?KX1"3?PD4]@H!*6_MP$-]($P[6(
MC\#--N(+/X1N)[-'8/F];3$I1NDA2![CB*-S""\Z[G/4*+B)Q%VI0GPLB==7
M.Z'\=#=OK"%59LPBG.@?&N FGS30 );K2H@QI\6'L)W=+S$  0MO1UKE:=1:
M_*I.O]CR"!*F1R)MD3"'P'*KJB%=$"G& J4CCGNE*N7(]3%I9DZG$\]3H&2$
M$][>CT4@+.RTN\=;-.'T.-"E2K;FU?.5KQ[6'#S-DHW3-SSD2< U='>;SJN>
MR%;A#D_EZBTS]AU:+X-KK3*NK> ^JC;'PW:G Y_;<,WT[81-X5JRD#=AF O+
M<4IG<XP,*,(E2Z,F?!#&T)\L$] _Z.[LK<5:;D2D$<;"(?1W'=%EUZX#P#>)
MA!+P0^_^+U]T=SM'W_?O,DM/4.IQ?CKD8:X%N18,^$@8! (>U4 7$#PP,(KO
M-"-HAZ%%_'90CB^72B<P;/6/M_+3,KR?9H__YL:*>+K*)$]VH\\<QNR. PLI
M S&#D)EC0I.8T&"J<A ICJ0I#YV@$V''-*P!\Q(E*Q4#>X0NX-4EY;&/J@W]
M?K_5V]W?[W5?PRNDQW!N--.PTF#R+)-N"X[.;<<<7K[8[_56F?J[O0]6X?)J
M.2H?11ZZ1Z])<M04SE@"R4(]Q'#-B3!"X>U].&8I)N0+E204J;CZU08%FY%=
M%";+M<D9$D=S+S!^%EHR;_>@WV_"S% ;97S&SBP"D:]%*30"H25W]%+HNB%1
M!AI3<8QT<$XPA;7"V,-9"=4&'YB>$DIC%.E,>9;F5.@AXOE=(&/I=/W4&I49
MFGYS!PKI%"5. BR#2R.8F6MYD]AIAB\FXZ&(!=708\1:D;8+8%^OE6Z0W@,X
M%? 0?1LX.@BB'&)AGN'W'N"JD*Z%[JK8;\^E,B2%WL;3D(,P6#-&G%R3<%-E
M(J4])+>862!RA?]:)5V&)<\:>:%(0YE'!=+7RM R<%9KJ#0(Y@JF.41<HI9<
M+-DQBC?#:SSN+,BW(GT0G4PK,KO-ZZLWBBS7,PZ&%0</0OUF#(3(Y#V-0K72
M5@E]-0^LP_8@Q\RZW=OVA<DRBI?FHQ!8*7:!GSC9>T$=*NL,8=@BROVTM]-I
MXI&)_I)]\32F<>U&TX(CN6@MCRJ>6QKN[AU109,DJ#)C57C;A(QIN&,RY_!3
MIXT2= $ANY!AXRG9Q1ARM2!($UF^HZJSU/\#45GZ!=FUT(@+SX 7A5GLMJ"@
M-TBR[C)K]>;"X9@D7QLAXDW+W@<R<3;2W/':]$"W[/I_0BK\(V:?,T>22<DD
M ;<3SM.Y\*)Q3WN@4$F6#IKG3.@(7K(D.\*)E<VQO/#U!-7(YQ__ Q^XE.@>
M%RP3A,-8=]QRBQQ<75W@!!6?U5"A+$_.;]Z_\S-^X2[H40KW.F!3=,\(?F$D
M6$'^S!@5"@**<CTYIDI-'6_<ZB%+<CQ"G+5QGT1H_J42P$E:+K]Y4U_YZE_#
ML]>TWBGB,XICX)+ID:HS7LJ/T]9J'U?A&N<8#!W#FO9?Y^BF^9W@$XPNDX=C
MB'Q7L3AYN-+#C?-[I#2KQB2;D,@3OT=$KH]HD6%FSC09F9+!B*HAEQ%\5C?<
M(B,:\U+ I9K,"H/2+IXA*<@M*8&IW *)G7$G.U#A$(O0\=&DU!I2Q>Q&BL(P
MRP,I0L(O0?U3)X:S#O*3,"HJW+08#ZSTCMLQ626NU6RNI.,(^,UJ4;C42OJ!
M#(ZG:8+Q3)E9#?V@R*5EF3%YXHIK9@NLGJ4*K"9R_ K7X4D%S8[EZBP;\M_R
M0K/X[<AUJ*FX8&EI:MH+/4HD>>+7LASMK9'C:*%RJ')QH!BB&;(>(2J$5J'Z
M<2D2\ :D+ %T"L IF\S&'[P<UR3'8EU!<>2TERK@=ZZS$2(@&3=8:B-D.5F%
M>$YSE^+H%#13B*^2<+">^8'=,2%9@!4<&8'LP>C0L%!XH78"CB6U<333!2KX
MEF+QYXWIS>L83MB4%M;,3"OGA/V1_?WF8?^F8Y44B;#NZJ40JSQIO^,IU^BZ
M%[43]Q6;/*I)_)SBP%<T&TJ,TY/&^>#Z\AH3T#G&V^T9_E-=:X22,TW^:L?5
M)81561D"?@2_MBJI*%;W)P^1J+;/<*05T%"+Q98N,YB<L*FI;?+0-8S?H>#
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M  !E9W M,C R,C$R,39?;&%B+GAM;%!+ 0(4 Q0    ( .:%D%68L.S'V04
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I,# P-C(Y,W@R7V5X-2TQ+FAT;5!+!08     !@ & (L!  "AY      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
